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ABSTRACTS
This thesis encompasses two literature reviews (chapter 2 & 3) and two experimental
chapters (4 and 5) examining the available literature on exercise and cancer,
resistance training and its anabolic responses in older men and women, the side
effects of Androgen Deprivation Therapy (ADT) for prostate cancer and finally, the
role of resistance exercise as a clinical intervention to counteract such changes as an
adjuvant therapy.

REVIEW OF LITERATURE ONE
A REVIEW OF EXERCISE INTERVENTION STUDIES
UNDERTAKEN IN CANCER PATIENTS
Purpose: To present an overview of exercise interventions in cancer patients during
and after treatment and evaluate a dose training response considering type,
frequency, volume and intensity of training along with their expected physiological
outcomes.
Methods: The review is divided into studies that incorporated cardiovascular
training, combination of cardiovascular, resistance and flexibility training and
resistance training alone during and after cancer management. The criteria for
inclusion were based on studies sourced from electronic and non-electronic databases
and which incorporated pre- and post-intervention assessment with statistical
analysis of the data.
Results: Twenty-six published studies are summarized. The majority of the studies
demonstrate physiological and psychological benefits. However, most of these
studies suffer limitations because they are not randomized controlled trials and/or use
small sample sizes. Predominantly, studies have been conducted with breast cancer
patients using cardiovascular training rather than resistance exercise as the exercise
modality. Recent evidence supports the use of resistance exercise or “anabolic
exercise” during cancer management as an exercise mode to counteract the side
effects of the disease and treatment.

iii

Conclusion: Evidence underlines preliminary positive physiological and
psychological benefits from exercise when undertaken during or after traditional
cancer treatment. As such, other cancer groups in addition to breast cancer should
also be included in clinical trials to address more specifically dose response training
for this population. Contemporary resistance training designs which provide a strong
anabolic effect for muscle and bone may have an impact on counteracting some of
the side effects of cancer management assisting patients to improve physical function
and quality of life.
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REVIEW OF LITERATURE TWO
ANABOLIC RESPONSES TO RESISTANCE TRAINING IN
OLDER MEN AND WOMEN: A BRIEF REVIEW
Resistance training has been shown to be the most effective exercise mode to induce
anabolic adaptations in older men and women. Advances in imaging techniques and
histochemistry have increased the ability to detect such changes confirming the high
level of adaptability that remains in aging skeletal muscle. This brief review presents
a summary of the resistance training studies which directly compare chronic anabolic
responses to training in older (> 60 years) men and women. Sixteen studies are
summarized; the majority of these studies indicate similar relative anabolic responses
between older men and women following resistance training. Relatively small
sample sizes in most of the interventions limited the ability to detect significant sex
differences and should be considered when interpreting these studies. Future research
should incorporate larger sample sizes with multiple measurement time points for
anabolic responses.
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EXPERIMENTAL STUDY ONE
CHANGES IN MUSCLE, FAT, AND BONE MASS AFTER 36
WEEKS OF MAXIMAL ANDROGEN BLOCKAGE FOR
PROSTATE CANCER
Objective: To assess the effects of androgen deprivation therapy (ADT) on whole
body and regional muscle, fat and bone mass in men with prostate cancer without
metastatic disease.
Patients and methods: Seventy-two men aged 44 to 88 years underwent spine, hip
and whole body dual-energy X-ray absorptiometry (DXA) scans at baseline and
following 36 weeks of ADT. Change in whole body and regional lean mass (LM), fat
mass (FM), and bone mineral content (BMC) and density (BMD) were determined.
In addition, PSA, serum testosterone and hemoglobin were assessed.
Results: Upper limb, lower limb, trunk, and whole body LM decreased by 5.6 ±
0.6%, 3.7 ± 0.5%, 1.4 ± 0.5% and 2.4 ± 0.4% (p < 0.01), respectively, while FM
increased by 20.7 ± 3.3%, 18.7 ± 2.7%, 12.0 ± 2.5%, and 13.8 ± 2.3% (p < 0.001).
Hip and spine BMD decreased by 1.5 ± 0.5% and 3.9 ± 0.4% (p < 0.001) as did
whole body (2.4 ± 0.3%) and upper limb (1.3 ± 0.3%) BMD, but not lower limb
BMD. Serum testosterone, PSA and hemoglobin decreased by 93.3% ± 0.4, 98.2% ±
0.5%, and 8.8 ± 0.9 (p < 0.001), respectively.
Conclusion: Thirty-six weeks of ADT resulted in a significant decrease in whole
body and regional lean mass and bone mass, while whole body and regional fat mass
increased in older men with prostate cancer. Strategies to counteract changes in soft
tissue and bone mass during ADT should be formulated to minimize risk of
sarcopenia, osteoporosis, and obesity.
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EXPERIMENTAL STUDY TWO
RESISTANCE TRAINING AND REDUCTION OF PHYSICAL
TREATMENT SIDE EFFECTS IN PROSTATE CANCER
PATIENTS
Purpose: To examine the effect of progressive resistance training on muscle
function, functional performance, balance, body composition and muscle thickness in
men receiving androgen deprivation for prostate cancer.
Methods: Ten men aged (59-82 years) on androgen deprivation for localised prostate
cancer undertook progressive resistance training for 20 weeks at 6-12 repetition
maximum for 12 upper and lower body exercises in a University exercise
rehabilitation clinic. Outcome measures included muscle strength and muscle
endurance for the upper and lower body, functional performance (repeated chair rise,
usual and fast 6-m walk, 6-m backwards walk, stair climb, and 400-m walk time) and
balance by sensory organization test. Body composition was measured by dual
energy x-ray absorptiometry and muscle thickness at four anatomical sites by BMode ultrasound. Blood samples were assessed for PSA, testosterone, growth
hormone (GH), cortisol, and hemoglobin.
Results: Muscle strength (chest press, 40.5%; seated row, 41.9%; leg press, 96.3%; p
< 0.001) and muscle endurance (chest press, 114.9%; leg press, 167.1%; p < 0.001)
significantly increased following training. Significant improvement (p < 0.05)
occurred in the 6-m usual walk (14.1%), 6-m backwards walk (22.3%), chair rise
(26.8%), stair climbing (10.4%), 400-m walk (7.4%) and balance (7.8%). Muscle
thickness increased (p < 0.05) by 15.7% at the quadriceps site. Whole body lean
mass was preserved with no change in fat mass. There were no significant changes in
PSA, GH, testosterone, cortisol, or hemoglobin.
Conclusions: Progressive resistance exercise has beneficial effects on muscle
strength, functional performance and balance in older men receiving androgen
deprivation for prostate cancer and should be considered to preserve body
composition and reduce physical side effects associated with treatment.
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Chapter 1
INTRODUCTION
Worldwide 15 million new cases and 10 million new deaths from all cancers
are expected by the year of 2020 (Parkin, Bray, Ferlay, & Pisani, 2001). In this
context, prostate cancer is the sixth most common cancer representing 14.3% of
cancers among men in developed countries (Parkin, Pisani, & Ferlay, 1999).
Nevertheless, the mortality rate for prostate cancer has declined over the past several
years in many developed countries (Baade, Coory, & Aitken, 2004). It has been
suggested that the prostate-specific antigen (PSA) screening that was introduced in
North America in the late 1980s had a significant role on early detection of the
disease contributing to the increased survival rates viewed in the last decade (Oliver,
May, & Gunnell, 2001). Given that the life expectancy from prostate cancer patients
has increased, clinical interventions aimed at decreasing levels of fatigue, promoting
physiological and psychological adaptations, and improving quality of life treatment
are relevant.
Recently, Denmeade and Isaacs (2004), in their comprehensive review of the
historical development of prostate cancer treatments, reported that although there was
a remarkable increase in the number of prostate cancer diagnostics over the last 150
years, understanding related to the specific biology of prostate cancer and its
treatments (androgen deprivation treatment (ADT), prostatectomy, radiation, prostatic
brachytherapy and systematic therapy) had developed only over the past 30 years.
The traditional treatments for prostate cancer that focus on reducing the levels or
effects of testosterone by ADT have many undesirable side effects (Diamond,
Higano, Smith, Guise, & Singer, 2004; Hedlund, 2000; Holzbeierlein, McLaughlin, &
Thrasher, 2004; Pickett, Bruner, Joseph, & Burggraf, 2000; Stege, 2000). Some of
these physical side effects include increased fat mass, reduction of muscle and bone
mass, altered lipid profiles, anemia and gynecomastia which have negative
implications for physiological and psychological function (Cassileth et al., 1992;
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Cleary, Morrissey, & Oster, 1995; Diamond, Higano, Smith, Guise, & Singer, 2004;
Hedlund, 2000; Holzbeierlein, McLaughlin, & Thrasher, 2004; Michaelson, Marujo,
& Smith, 2004; Pickett, Bruner, Joseph, & Burggraf, 2000; Stege, 2000).
Only scant information on alterations to bone mass and soft-tissue following
ADT exist (Smith, 2004; Smith et al., 2002; Tayek et al., 1990), and there is no
information on changes in bone density levels at various regional sites, regional lean
and fat mass (i.e. trunk, upper, and lower limb) during therapy. Abdominal fat has
been related to increased risk for the development of cardiovascular complications,
thus, if ADT tends to induce greater trunk fat accumulation, alternative or adjuvant
therapies should be devised to counteract such conditions. Similarly, are losses in
muscle and bone mass greater at weight-bearing sites than non-weight bearing sites
and can strategies be incorporated into the patient’s management plan to address this?
Moreover, these changes in body composition and tissue distribution can be directly
related to chronic conditions that result in disability and loss of independence in older
adults.
Existing treatments to alleviate these side effects have been predominantly
pharmaceutical, however, these treatments are expensive, with the cost benefit ratio
questionable and their effects do not translate into improved physical function or
decreased levels of fatigue (Smith et al., 2003; Smith et al., 2001).
Considering that the life expectancy for prostate cancer patients has increased,
additional information on how bone mass and body composition adapts during ADT
seems relevant so that appropriate to counter the physiological side effects can be
devised and recommended.
To date, most of the experimental studies examining the role of exercise
during cancer treatments have included breast cancer patients (MacVicar,
Winningham, & Nickel, 1989; Mock et al., 1997; Mock et al., 2001; Schwartz, Mori,
Gao, Nail, & King, 2001; Winningham & MacVicar, 1988; Winningham, M. L.,
M.G. MacVicar, M. Bondoc, J.I. Anderson, & J.P. Minton, 1989) and other types of
cancer (Cunningham, Morris, & Cheney, 1986; Dimeo, Fetscher, Lange,
Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul, 1998; Dimeo, Tilman et
al., 1997; Dimeo, Stieglitz, Novelli-Fischer, Fetscher, & Keul, 1999), but have not
included prostate cancer patients undertaking ADT. Moreover, most exercise
interventions included aerobic exercise (Courneya et al., 2003; Dimeo, Fetscher,
Lange, Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul, 1998; Dimeo,
2
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Stieglitz et al., 1997; Dimeo, Tilman et al., 1997; Dimeo, Stieglitz, Novelli-Fischer,
Fetscher, & Keul, 1999; MacVicar, Winningham, & Nickel, 1989; Mock et al., 1997;
Mock et al., 2001; Schwartz, 1999; Schwartz, 2000; Segal et al., 2001; Winningham,
M. L., M. G. MacVicar, M. Bondoc, J. I. Anderson, & J. P. Minton, 1989) rather than
resistance exercise. In view of the extensive scientific literature supporting resistance
training as being the most effective anabolic exercise method available for improving
muscle strength, muscle hypertrophy and bone mineral density (Charette et al.,
1991b; Fiatarone et al., 1990; Fiatarone et al., 1994; Frontera, Meredith, O'Reilly,
Knuttgen, & Evans, 1988a; Hakkinen et al., 1998a; Hakkinen et al., 1996; Nelson et
al., 1994; Newton et al., 2002; Taaffe, Pruitt, Pyka, Guido, & Marcus, 1996; Taaffe et
al., 1994; Wolff, van Croonenborg, Kemper, Kostense, & Twisk, 1999), resistance
exercises may have a role to play counteracting the catabolic side effects of ADT by
promoting a sufficient anabolic environment which can lead to positive effects on the
musculoskeletal system. A preliminary report from Segal and associates (2003)
recently examined the effects of a short-term period of resistance exercise on patients
diagnosed with prostate cancer undertaking ADT. Although the results support
positive psychological and physical outcomes, questions remain as to how specific
physical and physiological parameters such as muscle function, functional
performance, balance, body composition and bone mineral density would adapt with
resistance training in long-term trials. Given the fact that ADT usually occurs over a
two to three year period, but can also occur over a 20 year time frame (Schroder,
2000), the role of resistance exercise for prolonged periods of time may be even more
relevant for reducing the catabolic conditions produced by ADT. Therefore, the
purpose of the present research is to: 1) explore the available literature in the area of
exercise interventions during and after cancer therapy and propose possible guidelines
for exercise during cancer treatment, 2) review and identify the anabolic effects
following resistance training interventions in older adults, 3) examine the effects of
ADT in regional body composition, bone mass, bone markers and hemoglobin in a
large cohort of men with localized prostate cancer receiving maximal androgen
blockage by Luteinizing Hormone-Realizing Hormone Agonist (LRHRa) and
antiandrogen during 36 weeks, and 4) investigate the effects of a 20-week high
intensity progressive resistance training on muscle function, functional performance,
balance, body composition, muscle thickness, bone mineral density, serum hormones
and PSA in prostate cancer patients on undergoing established ADT.
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SIGNIFICANCE
Considering the notable impact of prostate cancer in the male population
world wide and that the life expectancy from prostate cancer patients has increased,
clinical interventions aimed to decrease levels of fatigue, promote physical and
physiological adaptations and improve quality of life during treatment are necessary.
Thus, resistance exercise may have a potential role to counteract the catabolic side
effects of ADT promoting a sufficient anabolic environment that can lead to positive
effects on the musculoskeletal system. Moreover, because ADT may be continued for
as long as 20 years, the role of resistance exercises may be especially relevant in
improving physical and physiological parameters and consequently, quality of life.
As such, the findings from this study may have important application to exercise
prescription in prostate cancer patients undertaking ADT.

PURPOSE
The aims of this project are to test several research questions:
Experiment 1:
1) Is regional body composition affected following maximal androgen blockage
in prostate cancer patients?
2) Is regional bone mineral density affected following maximal androgen
blockage in prostate cancer patients?
3) Are levels of hemoglobin and bone markers altered following maximal
androgen blockage in prostate cancer patients?
Experiment 2:
1) Is muscle function increased following resistance exercise in prostate cancer
patients?
2) Is functional performance increased following resistance exercise in prostate
cancer patients?
3) Is balance improved following resistance exercise in prostate cancer patients?
4) Is body composition (total lean and fat mass) altered following resistance
exercise in prostate cancer patients?
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5) Is muscle thickness increased following resistance exercise in prostate cancer
patients?
6) Are systemic levels of serum hormones, PSA, and blood cells altered
following resistance exercise in prostate cancer patients?

5

DEFINITIONS OF TERMS
Prostate cancer: “A malignant tumor (carcinoma) of the prostate gland, a common
cancer in elderly men. In most men it progresses slowly over many years and the
gives symptoms similar to those of benign enlargement of the prostate.”(Martin,
2002)
Prostate Specific Antigen (PSA): “An enzyme produced by the glandular epithelium
of the prostate. Increased quantities are secreted when the glands enlarge, and levels
of PSA in the blood are significantly elevated in cancer of the prostate. Although
there is no clear “cut-off” level for normality, over 4 ng/ml in the blood is associated
with a 20% risk of prostate cancer, even in patients with normal-feeling prostates on
rectal examination. Newer PSA assays can measure free PSA and compare it to the
total PSA in the blood. Low free: total PSA ratios indicate greater risk of prostate
cancer and improve the discrimination between cancer and benign disease in men
with PSA in the range 4-10ng/mg. PSA levels tend to be much higher in advanced
prostate cancer and the rate of fall on the treatment is a good prognostic indicator of
response.” (Martin, 2002)
Sarcopenia: The loss of muscle mass with aging (Evans, 1995).
Osteoporosis: “Loss of bony tissue, resulting in bones that are brittle and liable to
fracture. Infection, injury and synovitis can cause localised osteoporosis of adjacent
bone. Generalised osteoporosis is common in the elderly, and in women often follows
menopause. It is also a feature of Cushing’s syndrome and prolonged steroid therapy.
Osteoporosis can be detected by the quantitative digital radiography and by DEXA
scans. A diet with adequate calcium, exercise, and hormone replacement are
preventative, and bisphosphonates can be used to reduce or halve further bone loss.”
(Martin, 2002)
Dual X-ray absorptiometry (DXA): “A method of measuring bone mineral density
based on the proportion of a beam of photons that passes through the bone.” (Martin,
2002)
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Introduction
A progressive increase of cancer burden with an estimated 15 million new
cases and 10 million new deaths are expected by the year of 2020 (Parkin, Bray,
Ferlay, & Pisani, 2001). In this context, prostate cancer is the sixth most common
cancer in the world representing 14.3% of cancers among men in developed
countries with more than 80% of the cases occurring in men older than 65 years
(Parkin, Pisani, & Ferlay, 1999). Breast cancer appears as the third most common
cancer in the world and it is ranked as the fifth most prevalent cause of death from
cancer overall being the leading cause of cancer mortality in women (Parkin, Pisani,
& Ferlay, 1999). Treatments for cancer include surgery, systemic and radiation
therapy and have successfully shown reductions in mortality rates. However, for
cancer patients, the increased levels of fatigue during treatment remains a concern as
it affects the majority of patients during radiotherapy and/or chemotherapy periods
compromising their physical function and quality of life (Dimeo, 2002; Dimeo, 2001;
Irvine, Vincent, Graydon, Bubela, & Thompson, 1994; Irvine, Vincent, Graydon, &
Bubela, 1998; Smets, Garssen, Schuster-Uitterhoeve, & de Haes, 1993; Smets,
Visser, Willems-Groot, Garssen, Oldenburger et al., 1998; Smets, Visser, WillemsGroot, Garssen, Schuster-Uitterhoeve et al., 1998). Dimeo (2002; , 2001) has
proposed that the lack of physical activity during treatment may affect the increased
levels of fatigue observed during and after cancer management. As such, several
studies examining the role of exercise with cancer patients have linked the increased
levels of physical activity during (Adamsen et al., 2003; Courneya et al., 2003;
Dimeo, Fetscher, Lange, Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul,
1998; Dimeo et al., 2003; Dimeo, Stieglitz et al., 1997; Dimeo, Stieglitz, NovelliFischer, Fetscher, & Keul, 1999; Kolden et al., 2002; MacVicar, Winningham, &
Nickel, 1989; Mock et al., 1997; Mock et al., 2001; Na, Kim, Kim, Ha, & Yoon,
2000; Segal et al., 2003; Winningham, M. L., M.G. MacVicar, M. Bondoc, J.I.
Anderson, & J.P. Minton, 1989) and after cancer treatment (Dimeo, Tilman et al.,
1997; Durak & Lilly, 1998; Durak, Lilly, & Hackworth, 1999; Nieman et al., 1995;
Peters, Lotzerich, Niemeier, Schule, & Uhlenbruck, 1994; Peters, Lotzerich,
Niemeir, Schule, & Uhlenbruck, 1995; Porock, Kristjanson, Tinnelly, Duke, &
Blight, 2000; Segar et al., 1998; Sharkey, Carey, Heise, & Barber, 1993) with

positive effects on decreasing rates of fatigue, enhancing physical performance and
quality of life. However, the majority of the exercise interventions undertaken with
this population have focused on cardiovascular training (Courneya et al., 2003;
Dimeo, Fetscher, Lange, Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul,
1998; Dimeo, Stieglitz et al., 1997; Dimeo, Tilman et al., 1997; Dimeo, Stieglitz,
Novelli-Fischer, Fetscher, & Keul, 1999; MacVicar, Winningham, & Nickel, 1989;
Mock et al., 1997; Mock et al., 2001; Schwartz, 1999; Schwartz, 2000; Segal et al.,
2001; Winningham, M. L., M. G. MacVicar, M. Bondoc, J. I. Anderson, & J. P.
Minton, 1989), with few studies using the combination of aerobic and resistance
exercises (Adamsen et al., 2003; Durak & Lilly, 1998; Durak, Lilly, & Hackworth,
1999; Kolden et al., 2002; Nieman et al., 1995; Porock, Kristjanson, Tinnelly, Duke,
& Blight, 2000) or resistance exercise alone (Cunningham, Morris, & Cheney, 1986;
Segal et al., 2003). Therefore, little is known as to the effect of resistance training
being a primary exercise choice to counteract some of the physiological conditions
accompanied by cancer disease and the traditional treatments. Considering that most
of the experimental exercise studies have incorporated breast cancer patients
(MacVicar, Winningham, & Nickel, 1989; Mock et al., 1997; Mock et al., 2001;
Schwartz, Mori, Gao, Nail, & King, 2001; Winningham & MacVicar, 1988;
Winningham, M. L., M.G. MacVicar, M. Bondoc, J.I. Anderson, & J.P. Minton,
1989) and other types of cancer (Cunningham, Morris, & Cheney, 1986; Dimeo,
Fetscher, Lange, Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul, 1998;
Dimeo, Tilman et al., 1997; Dimeo, Stieglitz, Novelli-Fischer, Fetscher, & Keul,
1999) but not prostate cancer, there is a particular lack of information on how
prostate cancer patients undertaking traditional treatment would respond to an
exercise program and yet given the documented effects of androgen deprivation
therapy (ADT) (Cassileth et al., 1992; Cleary, Morrissey, & Oster, 1995; Diamond,
Higano, Smith, Guise, & Singer, 2004; Hedlund, 2000; Holzbeierlein, McLaughlin,
& Thrasher, 2004; Michaelson, Marujo, & Smith, 2004; Pickett, Bruner, Joseph, &
Burggraf, 2000; Stege, 2000) these patients should benefit particularly from
resistance exercise. To date, only one published paper has examined the effects of a
short-term resistance exercise program on patients diagnosed with prostate cancer
and undertaking ADT (Segal et al., 2003). Interestingly, they reported quite
promising results. In view of the extensive scientific literature supporting resistance
training as being the most effective method available for improving muscle strength
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and increasing lean tissue mass in different populations ranging from athletes to frail
older adults (Charette et al., 1991b; Fiatarone et al., 1990; Fiatarone et al., 1994;
Frontera, Meredith, O'Reilly, Knuttgen, & Evans, 1988a; Hakkinen et al., 1998a;
Hakkinen et al., 1996; Kraemer et al., 1999b; Kraemer et al., 2003; Newton et al.,
2002; Taaffe, Pruitt, Pyka, Guido, & Marcus, 1996; Taaffe et al., 1994), resistance
exercise may also have a great potential to counteract the side effects of prostate
cancer during ADT by increasing muscle function, lean tissue mass and bone mineral
density with subsequent reduction in levels of fatigue.
There are specific training variables involving resistance exercise prescription
which include number of sets and repetitions (volume), intensity of training (load),
duration of rest between sets and exercises, frequency of training and repetition
velocity (American College of Sports Medicine, 1998b; Kraemer et al., 2002;
Kraemer & Ratamess, 2004). Currently, there is no information with regard to such
training variables and possible variations with cancer patients undertaking resistance
training programs. Interestingly, some of these variables have been examined in
untrained older adults (Galvão & Taaffe, 2004; Hunter et al., 2001; Taaffe, Duret,
Wheeler, & Marcus, 1999; Taaffe, Pruitt, Pyka, Guido, & Marcus, 1996; Vincent et
al., 2002) and favourable responses in strength and function result from a variety of
training regimens, even those that involve relatively low intensities (Taaffe, Pruitt,
Pyka, Guido, & Marcus, 1996; Vincent et al., 2002; Vincent, Vincent, Braith,
Bhatnagar, & Lowenthal, 2003), frequencies (Taaffe, Duret, Wheeler, & Marcus,
1999) and volume (Galvão & Taaffe, 2004; Taaffe & Galvão, 2004). Considering the
detrained state and high levels of fatigue of many cancer patients, it may be expected
that even a training program consisting of lower intensity, volume and frequency
could significantly promote positive physiological and psychological adaptations
increasing quality of life in this population.
The purpose of this paper is to present a descriptive overview and
chronological perspective of developments of the experimental exercise intervention
studies undertaken during and after cancer management. The second aim of this
review attempts to establish a dose response of training for this population
considering type of exercise, frequency of training, volume of training, intensity of
training and expected physiological outcome measures. In addition, we also highlight
specific points that should be examined in the future with the goal of obtaining more
information on exercise prescription for this population. This review reports 26
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published studies appearing in the Medline (electronic version of Index Medicus)
database, published by June of 2004 and searched by the terms: exercise;
cardiovascular training; resistance training; rehabilitation; and cancer. Secondary
searching involved scanning the reference lists from the papers identified above and
then locating papers which appeared useful in reviewing the topic. A key criterion
throughout this process was identifying studies which incorporated pre- and postintervention assessment with statistical analysis of the data.

Experimental Exercise Studies during Cancer Treatment
A summary of the published studies examining the effect of exercise on
cancer patients undertaking treatment is shown in Table I. Out of the 18 experimental
exercise interventions under cancer treatment, 14 had used some type of
cardiovascular training (Courneya et al., 2003; Dimeo, Fetscher, Lange,
Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul, 1998; Dimeo et al., 2003;
Dimeo, Stieglitz, Novelli-Fischer, Fetscher, & Keul, 1999; MacVicar, Winningham,
& Nickel, 1989; Mock et al., 1997; Mock et al., 2001; Na, Kim, Kim, Ha, & Yoon,
2000; Schwartz, 1999; Schwartz, 2000; Schwartz, Mori, Gao, Nail, & King, 2001;
Segal et al., 2001; Winningham & MacVicar, 1988; Winningham, M. L., M.G.
MacVicar, M. Bondoc, J.I. Anderson, & J.P. Minton, 1989), two had used a mixed
training program using cardiovascular, resistance and flexibility exercises (Adamsen
et al., 2003; Kolden et al., 2002) while the other two studies applied a structured
resistance training program (Cunningham, Morris, & Cheney, 1986; Segal et al.,
2003). The main outcome measures from these studies include: levels of fatigue
(Mock, 2001a; Mock et al., 1997; Schwartz, 1999; Schwartz, Mori, Gao, Nail, &
King, 2001; Segal et al., 2003), quality of life, emotional-related distress (Adamsen
et al., 2003; Courneya et al., 2003; Dimeo, Stieglitz, Novelli-Fischer, Fetscher, &
Keul, 1999; Kolden et al., 2002; Mock et al., 1997; Mock et al., 2001; Schwartz,
1999; Segal et al., 2001), immunological parameters (Dimeo, Fetscher, Lange,
Mertelsmann, & Keul, 1997; Dimeo et al., 2003; Dimeo, Tilman et al., 1997; Na,
Kim, Kim, Ha, & Yoon, 2000), aerobic capacity (Adamsen et al., 2003; American
College of Sports Medicine, 1998b; Courneya et al., 2003; Dimeo, Fetscher, Lange,
12
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Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul, 1998; Dimeo et al., 2003;
Dimeo, Stieglitz, Novelli-Fischer, Fetscher, & Keul, 1999; Kolden et al., 2002;
MacVicar, Winningham, & Nickel, 1989; Mock et al., 1997; Mock et al., 2001;
Schwartz, 1999; Schwartz, Mori, Gao, Nail, & King, 2001; Segal et al., 2001;
Winningham, M. L., M.G. MacVicar, M. Bondoc, J.I. Anderson, & J.P. Minton,
1989) and muscle strength (Adamsen et al., 2003; Kolden et al., 2002; Segal et al.,
2003).

A. Cardiovascular training
The first study by Winningham and colleagues (1988) examined the effect of
a 10-week aerobic program performed three times per week on nausea responses of
breast cancer patients undertaking chemotherapy. Subjects were randomly assigned
to an exercise, placebo or control group. The exercise group improved significantly
more on symptoms of nausea compared to control and placebo (P < 0.05).
Considering that nausea is a consistent symptom experienced by cancer patients
during treatment, this preliminary data showed that cardiovascular training can safely
be incorporated during breast cancer traditional treatment and may decrease
symptoms of nausea. Winningham and colleagues (1989) also presented data related
to a sub-group of their earlier report (Winningham & MacVicar, 1988) which
examined the effect of a 10- to 12-week aerobic training program on body
composition responses of breast cancer subjects undertaking chemotherapy. Subjects
were randomly allocated to an exercise group which trained 3 times per week for 2030 minutes with intensity set at 60-80% of maximal heart rate or a control group
which did not receive the exercise treatment. Although elementary techniques for
body composition determination were used in this intervention, the results showed
enhanced adaptations for lean tissue mass of the training group compared to the
control group. Considering the specificity of the training program in this study
(aerobic exercise only), the relative increase in lean tissue mass may be attributed to
the decreased fat tissue.
The effect of a 10-week aerobic interval training program was also
investigated by MacVicar and associates (1989). Forty-five women with breast
cancer receiving chemotherapy were randomly assigned to an aerobic exercise group
(cycling training), a flexibility training group or a control group. Exercise intensity
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was set at 60-85% of the maximum heart rate reserve. Results demonstrated
differences for maximum oxygen uptake (VO2max) and testing time among groups
with the aerobic training group improving significantly more than the flexibility and
control group.
Mock and colleagues (1997) examined the effect of a home based exercise
program on women with breast cancer undertaking radiotherapy. The exercise
program consisted of a 20-30 minute self-paced walking program, 4-5 times per
week over 6 weeks. A 12-Minute Walk Test, Symptom Assessment Scales and the
Piper scale were used to assess physical function, symptoms experience and fatigue,
respectively. Results showed that subjects undertaking the exercise program had a
significant improvement in walking distance, symptom experience (anxiety,
depression and difficulty sleeping) and fatigue.
The effect of a daily bed cycling program during high-dose chemotherapy
treatment in cancer patients followed by autologous peripheral blood cells
transplantation was reported by Dimeo and associates (1997). Subjects from the
control group experienced significantly higher loss of physical performance levels
during hospitalization than the exercise group (p < 0.05). Moreover, other
physiological parameters such as duration of neutropenia, thrombopenia and severity
of diarrhea were significantly reduced after the exercise intervention (p < 0.05).
Dimeo and colleagues (1998) also reported the response of a 6-week cardiovascular
exercise program on fatigue and physical performance in a small sample of cancer
patients (n = 5) experiencing fatigue during treatment. A progressive walking
treadmill program up to 30-35 minutes with intensity set to elicit a blood lactate level
of 3 mmol.L in capillary blood was prescribed. At the end of the intervention,
walking distance, walking maximal performance, heart rate and lactate concentration
were improved (p < 0.05) demonstrating once more positive physiological responses
accrued with cardiovascular training. In addition, the authors also noted a clear
decrease in levels of fatigue at post-test. Subsequently in 1999, the same group of
investigators (Dimeo, Stieglitz, Novelli-Fischer, Fetscher, & Keul, 1999) also
examined a daily exercise protocol consisting of a supine bike program followed by
an interval training pattern for 30 minutes in cancer patients receiving high doses of
chemotherapy. Outcome measures included psychological distress and levels of
fatigue. It was demonstrated at the end of the intervention that subjects undertaking
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the exercise program significantly decreased psychological distress with no changes
in fatigue levels.
Schwartz and colleagues (2000; , 1999) reported results from a 8-weeks
exercise intervention in women with breast cancer undertaking chemotherapy. The
exercise program included a home-based walking program with self-paced intensity
measured by an accelerometer. Subjects who underwent the exercise program
demonstrated greater response in the physical performance assessment (12-minute
walk test), as well as decreasing levels of fatigue compared to subjects who did not
adopt the training program (p < 0.05).
The short-term effect of cardiovascular training on natural killer cell
cytotoxic activity (NKCA) in stomach cancer patients were reported by Na and
associates (2000). Subjects were assigned to an exercise group which performed 30
minutes of supervised cardiovascular training using arm and cycle ergometer or a
non-exercise control group. Blood samples were collected at baseline, day 7 and day
14. At post-test a significantly greater increase in NKCA was noted for the exercise
group (27.9%) compared to the control group (13.3%) (p < 0.05). Although the
training period was short in duration, it is interesting to note that both groups had
similar values for NKCA at the midpoint of intervention, with the differences
between groups occurring during the second half of the training period.
Schwartz and colleagues (2001) also investigated the relationship of fatigue
and exercise through a home-based aerobic exercise program consisting of a 12minute walk in women undergoing chemotherapy treatment for breast cancer.
Functional abilities were assessed through a 12-minute walk test and fatigue levels
by a self-reported instrument. The exercise program increased functional ability by
15% whereas the non-exercisers decreased performance by 16%. In addition,
decreased levels of fatigue (p < 0.01) for the exercise group were observed after the
intervention. It is interesting to note that the exercise program was unsupervised with
none of the sessions being accompanied by an exercise physiologist. Considering
that training program variables were not well controlled during training, the results
are somewhat attractive and one would expect even greater adaptations for an
exercise program that incorporates a more controlled setting resulting in an enormous
impact on the outcome measures with this population.
The effect of a similar home-based walking exercise intervention on breast
cancer patients undertaking either radiotherapy or chemotherapy was also examined
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by Mock and colleagues (2001). The exercise program consisted of a progressive
walking (10-30 minutes) program 5 to 6 days per week with an unspecified training
intensity. Similar to Schwartz and colleagues (2001) and their previous report (Mock
et al., 1997), physical function was assessed by the 12-Minute Walk Test. In addition
fatigue and emotional distress were measured by the Pipe scale and Profile of Mood
States (POMS), respectively. Consistent with their previous findings (Mock et al.,
1997), the exercise intervention lead to a significant improvement in physical
performance by increasing walking distance. Additionally, fatigue and emotional
distress were enhanced at post-test indicating once more that positive psychological
outcomes may be achieved with a simple home-based walking exercise program.
Segal and colleagues (2001) conducted a randomized controlled trial
examining the effect of a supervised and unsupervised walking program on breast
cancer patients undertaking treatment (radiotherapy, hormonal therapy or
chemotherapy) over 26 weeks. Aerobic capacity, body weight and generic and
disease-specific health related quality of life were assessed (MOS SF-36) at baseline
and post-test. Results demonstrated that physical function measured by the MOS SF36 decreased in the control group while it increased in both training groups (p <
0.05). At post-test, no differences among groups were detected for quality of life,
aerobic capacity or body weight. However, when groups were stratified by type of
adjuvant therapy, in this case not receiving chemotherapy, differences in
improvement were observed between the supervised and control group for aerobic
capacity (p < 0.01). It is relevant to point out that the small changes in aerobic
capacity (3.5%) may be related to the nonspecific aerobic capacity test protocol
(stepping ergometer) utilized by the authors to assess chronic response of a walking
program.
The effect of 2-weeks of cardiovascular training on a mixed cancer
population undergoing conventional or high-dose chemotherapy during
hospitalization was examined by Dimeo and associates (2003). The training program
consisted of a daily walking treadmill interval training program with intensity set at
70% of the maximum heart rate. Submaximal stress test results demonstrated that
physical performance remained unaltered during treatment with significant
reductions in hemoglobin levels at hospital discharge (p < 0.05). Although physical
performance did not change at post-test, results demonstrated that cardiovascular
training may assist on preserving performance status during intensive chemotherapy.
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Finally, Courneya and associates (2003) conducted a randomized controlled
trial examining the effect of a home based exercise program on quality of life and
cardiovascular capacity of colorectal cancer patients undertaking adjuvant therapy.
The exercise group was instructed to perform cardiovascular and flexibility activities
3-5 times per week over 16 weeks while the control group advised to not participate
in any exercise activity during the study period. No significant differences were
observed between groups for quality of life and cardiovascular capacity at the end of
the intervention. The failure to detect differences between groups is primarily
explained by the fact that 51.6% of the control group did not comply with the study
and exercised during the study period. The nature of the exercise itself (home based
program) was pointed out by the authors as being one possible reason of the high
contamination during the intervention with little effectiveness.

B. Cardiovascular, resistance and flexibility training
Kolden and associates (2002) examined the effect of an exercise training
intervention including cardiovascular, resistance and flexibility training over 16
weeks in breast cancer patients undertaking some type of adjuvant therapy
(radiotherapy, chemotherapy or hormonal therapy). Subjects were tested for resting
blood pressure, body composition, aerobic capacity, flexibility and strength. In
addition, numerous psychological outcomes were also examined using the Beck
Depression Inventory, State-Trait Anxiety Inventory, Positive and Negative Affect
Schedule, Hamilton Scale for Depression, Quality of Life and Global Assessment
Scale. At the end of the intervention, there was an observed effect for time for upper
and lower body strength, cardiovascular capacity (estimated VO2 maximum),
flexibility, and resting systolic blood pressure (p < 0.05). Additionally, subjects
experienced positive psychological adaptations with training improving some of the
Quality of Life measures.
Recently, Adamsen and colleagues (2003), examined the effect of a high
intensity supervised exercise program on a mixed cancer population over 6-weeks.
The training program included interval training with intensity set at 60 to 100% of
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the maximal heart rate, resistance exercises performed at 85 to 95% of 1-RM for 5-8
repetitions and relaxation training. The results demonstrated an increase of 32.5% in
maximal strength (p < 0.0001) and 16% improvement in VO2max (p < 0.001).
Several measures of quality of life were also improved however no statistical
significant were noted. It is relevant to highlight that this is the first study which
incorporates a higher intensity training design, however, the absence of a control
group and the short duration of the intervention limited the interpretation of the data.

C. Resistance training
The earliest published study examining the effects of resistance exercise was
a short-term intervention involving patients with acute leukemia undertaken by
Cunningham and associates (1986). Subjects were randomly assigned to two exercise
groups performing the program either three or five times weekly or a non-exercising
control group. The training program consisted of several upper and lower body
exercises including the chest press, biceps curl, triceps extension, straight leg raises,
knee extension, hip extension, hip abduction, shoulder retractors and sit-ups
performed with 15 repetitions at an unspecified intensity. Outcome measures
included skinfold measures, arm circumference, nitrogen balance and creatinine
excretion. Results indicated that groups did not change arm circumference and
skinfold measures over the course of the intervention. Although, there were no
differences among groups for nitrogen balance during the course of the study, the
authors suggested that the exercise program favored both training groups with the
control group decreasing levels of creatinine excretion from pre-to post-test (p <
0.05).
Recently, Segal and colleagues (2003) reported the results from a 12-week
whole body resistance training intervention in prostate cancer patients undergoing
ADT. The resistance training program consisted of two sets of eight to 12 repetitions
at 60 to 70% of 1RM for six upper body and three lower body exercises performed
three times per week. Outcome measures included fatigue, disease-specific quality of
life assessment, and muscle strength and body composition. Results showed positive
effects of resistance training on decreasing fatigue levels, health-related quality of
life and muscle strength with no changes in body composition by the subjects
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embarking on the exercise program. The fact that body composition was unaffected
by the training program may be related in part to the elementary body composition
methods used to assess changes in muscle and fat tissue. In addition, it is well know
that strength gains during the first stages of resistance training are predominantly due
to neural factors with gains in muscle size becoming dominant as training continues
(Sale, 1987, 1988; Sale, MacDougall, Upton, & McComas, 1983). Consequently, the
shorter duration of the intervention and the limitations on body composition
assessment methods indicated that increases in strength were likely to be related to
neural alterations rather than muscle morphological changes. This preliminary data
showed optimistic outcomes with a resistance training program which is
characterized primarily by anaerobic energy sources rather than aerobic. Taking into
consideration that immunological parameters were not assessed in this particular
study, it remains to quantify if resistance training may positively alter the immune
system of patients under cancer treatment. In addition, it would be interesting to
examine how other types of cancer patients would respond with resistance exercises.

Experimental Exercise Studies after Cancer Treatment
Experimental studies examining the effect of exercise on cancer patients after
treatment are presented in Table II. Four studies had used cardiovascular exercise
programs (Dimeo, Tilman et al., 1997; Peters, Lotzerich, Niemeier, Schule, &
Uhlenbruck, 1994; Peters, Lotzerich, Niemeir, Schule, & Uhlenbruck, 1995; Segar et
al., 1998; Sharkey, Carey, Heise, & Barber, 1993) while the other four implemented
a mixed training program using cardiovascular, resistance and flexibility exercises
(Durak & Lilly, 1998; Durak, Lilly, & Hackworth, 1999; Nieman et al., 1995;
Porock, Kristjanson, Tinnelly, Duke, & Blight, 2000). Levels of fatigue, muscle
strength (Durak & Lilly, 1998; Nieman et al., 1995), cardiovascular function (Dimeo,
Tilman et al., 1997; Durak & Lilly, 1998; Durak, Lilly, & Hackworth, 1999; Nieman
et al., 1995; Peters, Lotzerich, Niemeier, Schule, & Uhlenbruck, 1994; Peters,
Lotzerich, Niemeir, Schule, & Uhlenbruck, 1995; Sharkey, Carey, Heise, & Barber,
1993), immunological parameters (Dimeo, Tilman et al., 1997; Nieman et al., 1995;
Peters, Lotzerich, Niemeier, Schule, & Uhlenbruck, 1994; Peters, Lotzerich,
Niemeir, Schule, & Uhlenbruck, 1995), symptoms of emotional-related distress and
quality of life (Durak & Lilly, 1998; Durak, Lilly, & Hackworth, 1999; Peters,
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Lotzerich, Niemeier, Schule, & Uhlenbruck, 1994; Porock, Kristjanson, Tinnelly,
Duke, & Blight, 2000; Segar et al., 1998) were the major outcome measures from
these studies.

A. Cardiovascular training
Sharkey and associates (1993) conducted the first experimental exercise study
examining the chronic response of a 12-week cardiovascular training program on
children and young adults with mixed cancer diagnosis who had completed
chemotherapy for at least one year. Outcome measures included cardiovascular and
pulmonary physiological responses. Although, none of the physiological parameters
changed with training, exercise tolerance assessed by exercise time was increased
significantly (p < 0.05).
The effect of cardiovascular training on NKCA, monocytes and personality
was examined in a group of breast cancer survivors by Peters and colleagues (1994; ,
1995). Their training program consisted of 30-40 minutes cycling at approximately
60% of maximum heart rate performed five times per week during the first five
weeks of training with a subsequent reduction of training frequency for the following
six months completing a total 7 months training period. Although NKCA cell
numbers were unaltered over the course of the intervention, an increase in the
cytotoxic activity was noted at post-test. While the total number of leukocytes was
unchanged after the training program, significant changes in leukocyte subpopulations was detected with an increased number of granulocytes and a decreased
number of lymphocytes and monocytes (p < 0.05). The authors suggested that
cardiovascular training would possibly alter the number of specific receptors in the
surface membrane on monocytes. Moreover, satisfaction of life increased in the first
five weeks of training with a subsequent decrease during the other 6 months of the
intervention.
Dimeo and colleagues (1997) examined the effects of a cardiovascular
training program on maximal performance and hemoglobin levels of cancer patients
directly after hospital discharge. The exercise program consisted of 6-weeks
treadmill walking every week day with intensity set to

elicit a blood lactate

level of 3 mmol.L in capillary blood. Results indicated that subjects that underwent
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the exercise program showed a significant increase in maximal performance and
hemoglobin concentration compared to controls (p < 0.05).
The effects of 10 weeks of cardiovascular exercises on women who had
undergone breast cancer treatment were examined by Segar (1998) and associates.
Subjects were randomly allocated to an exercise group, exercise plus behavior
modification group or a control group in an experimental cross over design.
Symptoms of depression, state of anxiety and self-esteem were assessed by the Beck
Depression Inventory, the State Anxiety Inventory and the Rosenberg Self-Esteem
Inventory, respectively. At post-test, it was observed that the exercise group had
significantly less depression and state of anxiety compared to controls with no
differences between exercise and exercise plus behavior modification groups. After
the crossover, the controls also showed optimistic changes by decreasing depression
and state of anxiety showing positive psychological response accrued with
cardiovascular training.

B. Cardiovascular, resistance and flexibility training
The effects of an exercise program on breast cancer survivors who had
undergone surgery, radiation and chemotherapy were examined by Nieman and
colleagues (1995). Subjects were randomly assigned to an exercise or control group.
In addition to physical performance measures that included; symptoms-limited
exercise testing on the treadmill, 6-minute walk test and lower body strength,
immunological training response was also assessed by measuring NKCA and
concentrations of circulating immune cells. The training program included 30
minutes walking at 75% of heart rate maximum and seven different resistance
exercises performed for 12 repetitions at an unspecified intensity. Results indicated
significant improvement for the exercise group on six-minute walk distance test
compared to controls (p < 0.05). However, differences between groups were neither
observed for lower body strength nor natural killer cell cytotoxic activity. It should
be noted that the small sample size (n = 6 per group) limited the ability to detect
significant difference between groups.
Durak and colleagues (1998b) conducted an exercise intervention in a mixed
cancer patient population over 10 weeks. The exercise program was performed twice
weekly and consisted of cardiovascular training at their own perceived exertion,
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resistance training machines using unspecified intensity and flexibility exercises.
Outcome measures included quality of life (Modified Rotterdam Quality of Life
Survey), endurance capacity and a 4- to 6-repetition maximum strength test. Results
demonstrated an average increase of 43% for both upper and lower body strength
combined and a 41.4% increase in MET level from the first to the last session of the
exercise program. In addition, the quality of life assessment indicated a significant
improvement on participants’ ability to perform daily functions. The same group of
investigators (Durak, Lilly, & Hackworth, 1999) also examined the effect of a 20week cardiovascular and resistance training program on prostate, carcinoma and
leukemia survivors. The exercise protocol was described with little detail in the
original manuscript; therefore it is unclear what intensity and volume were applied
during the exercise intervention for both cardiovascular and resistance exercises. In
addition, neither strength maximum nor cardiovascular capacity tests were
implemented at pre-and post test becoming extremely difficult to analyze the authors
presented data. At post-test, subjects completed a quality of life survey with the same
questionnaire being reassessed in a two year follow-up period. It was reported that
the training protocol induced an increase of 38% and 52% for overall strength in the
prostate cancer and carcinoma/leukemia group, respectively. No significant change
was noted for aerobic capacity. It is interesting to point out the high level of
adherence to the exercise program from both groups with subjects from the prostate
cancer group having 100% compliance to the training program whereas the
carcinoma/leukemia group recorded 65% of adherence over the two year period.
Finally, Porock and associates (2000) investigated the effect of a short-term
home based exercise intervention in a mixed population of cancer patients. The
training program appears to include both cardiovascular and resistance exercises but
lacked an exact description of training program variables (intensity, frequency and
volume). Outcome measures included fatigue, anxiety, depression, symptoms of
distress and quality of life. Results indicated positive adaptations for depression and
anxiety with no change in fatigue levels. It should be noted that the short-term
duration of the intervention and the small sample size (n = 9) limited the ability to
detect significant changes with training.
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Discussion
The primary aim of this paper was to present an overview of published
studies undertaken with any cancer population during and after treatment.
Unfortunately, most of these studies suffer limitations because they are not
randomized controlled trials, use small sample sizes and/or report insufficient
scientific methodological criteria. Despite this, it appears that there is a reasonable
amount of data in the literature which underline preliminary positive physiological
and psychological benefits from exercise when undertaking during or after traditional
cancer treatment. It is interesting to point out that the early published report on
cancer and exercise by Cunningham and associates (1986) used resistance exercises
as the training modality which was based on the original work by Delorme (1948; ,
1950) who introduced the model of progressive workload with resistance exercises.
Subsequently, the majority of studies examining the effect of exercise on cancer
patients undertaking treatment completed from the late 1980’s to 2003 implemented
the cardiovascular training modality (Courneya et al., 2003; Dimeo, Fetscher, Lange,
Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul, 1998; Dimeo, Stieglitz,
Novelli-Fischer, Fetscher, & Keul, 1999; MacVicar, Winningham, & Nickel, 1989;
Mock et al., 1997; Mock et al., 2001; Na, Kim, Kim, Ha, & Yoon, 2000; Schwartz,
1999; Schwartz, 2000; Schwartz, Mori, Gao, Nail, & King, 2001; Segal et al., 2001;
Winningham & MacVicar, 1988; Winningham, M. L., M. G. MacVicar, M. Bondoc,
J. I. Anderson, & J. P. Minton, 1989) with only two intervention using the
combination of resistance, flexibility and cardiovascular training (Adamsen et al.,
2003; Kolden et al., 2002). Therefore, particular attention should be taken of the
recent report from Segal and colleagues (2003) who reported positive effects of
resistance exercises alone on rates of fatigue, health-related quality of life and muscle
strength in prostate cancer patients undertaking ADT. Although these results support
positive psychological and physical outcomes, it remains to be examined how
specific physiological parameters such as muscle tissue mass and bone mineral
density would respond with resistance exercises in this population especially in long
term trials. Recently, Smith and associates (2004) reported an increase of 11% of fat
mass and a decrease of 3.8% of lean free-bone tissue mass from a year long
prospective assessment of the effects of ADT on body composition responses
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evaluated by dual energy x-ray absorptiometry. Further, the concern related to the
negative effects of ADT on accelerating bone loss has been extensively reported in
the literature (Berruti et al., 2002; Daniell, 2001; Daniell et al., 2000; Diamond,
Campbell, Bryant, & Lynch, 1998; Diamond, Higano, Smith, Guise, & Singer, 2004;
Smith, 2002a; Smith et al., 2003; Smith et al., 2001; Stoch et al., 2001; Wei, J. T. et
al., 1999). As an alternative, resistance exercise studies in older adults have
consistently shown it to be a safe and effective strategy to counteract sarcopenia
(Charette et al., 1991b; Fiatarone et al., 1990; Fiatarone et al., 1994; Frontera,
Meredith, O'Reilly, Knuttgen, & Evans, 1988a; Hakkinen et al., 1998a; McCartney,
Hicks, Martin, & Webber, 1996b; Nelson et al., 1994; Taaffe, Pruitt, Pyka, Guido, &
Marcus, 1996) and preserve or induce gains in bone mineral density (Kerr, Morton,
Dick, & Prince, 1996; Nelson et al., 1994; Pruitt, Taaffe, & Marcus, 1995; Villareal
et al., 2003). Recently, Villareal and associates (2003) reported positive effects of a
nine months resistance training program on bone mineral density in older women
undertaking hormonal replacement. A meta-analysis undertaken by Wolff and
colleagues (1999) also proposes that resistance training preserves or reverses bone
loss of up to 1% per year in both femoral neck and lumbar spine sites for pre-and
post-menopausal women. Taking into consideration the long-term benefits of this
exercise modality on bone response, resistance training may have an important role
on reducing the effect of bone loss rate in prostate cancer men undertaking ADT.
Moreover, considering that traditionally ADT varies from 2-3 years, but can also
take up to 20 years (Schroder, 2000), the role of resistance exercise may be even
more relevant by improving psychological and physiological parameters and
therefore improving quality of life.
In the context of maintaining or increasing lean tissue content in healthy
elderly and various patient populations in which muscle and bone loss are
problematic, resistance exercise might be more appropriately termed “anabolic
exercise”. It is not surprising therefore that the many cardiovascular exercise
interventions with cancer patients have produced mixed results as such exercise does
not provide a strong anabolic effect for muscle and bone and may not elicit the
changes in endocrine status that are desirable in these patients.
It is interesting to note that among the different cancer types, breast cancer
has been the most common cancer type examined during exercise trials. Out of the
18 studies undertaken during treatment, nine had used exclusively breast cancer
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subjects (Kolden et al., 2002; MacVicar, Winningham, & Nickel, 1989; Mock et al.,
1997; Mock et al., 2001; Schwartz, 1999; Schwartz, 2000; Schwartz, Mori, Gao,
Nail, & King, 2001; Segal et al., 2001; Winningham & MacVicar, 1988;
Winningham, M. L., M.G. MacVicar, M. Bondoc, J.I. Anderson, & J.P. Minton,
1989) with three studies including breast cancer plus a mixed of cancer populations
(Dimeo, Fetscher, Lange, Mertelsmann, & Keul, 1997; Dimeo, Rumberger, & Keul,
1998; Dimeo, Stieglitz, Novelli-Fischer, Fetscher, & Keul, 1999) and few other
experiments using, leukemia, stomach cancer, prostate, colon rectal and a mix
population of cancer types (Adamsen et al., 2003; Courneya et al., 2003;
Cunningham, Morris, & Cheney, 1986; Na, Kim, Kim, Ha, & Yoon, 2000; Segal et
al., 2003). A similar figure can be observed with the experimental trials undertaken
after cancer treatment where three studies were conducted with breast cancer patients
(Nieman et al., 1995; Peters, Lotzerich, Niemeier, Schule, & Uhlenbruck, 1994;
Peters, Lotzerich, Niemeir, Schule, & Uhlenbruck, 1995; Segar et al., 1998), three in
a mixed cancer population including breast cancer (Dimeo, Tilman et al., 1997;
Durak & Lilly, 1998; Porock, Kristjanson, Tinnelly, Duke, & Blight, 2000) and two
in a mixed cancer population not including breast cancer (Durak, Lilly, &
Hackworth, 1999; Sharkey, Carey, Heise, & Barber, 1993). Therefore, future studies
aiming to examine the role of exercises in cancer populations should also include
other cancer types than breast to reveal possible physiological and psychological
benefits from exercise among other cancer groups.
As a secondary purpose of this review we attempted to establish a training
dose response with this population based on the existing literature. The importance of
scientific exercise principles has been extensively reported (American College of
Sports Medicine, 1998a, 1998b; Kraemer et al., 2002; Kraemer & Ratamess, 2004).
It is well known that manipulation of the training program variables of frequency of
training, intensity of training, specificity of training and rest period between sets and
exercise sessions produces clearly differentiated effects on specific physiological
adaptations for both cardiovascular and resistance exercise. Nevertheless, long-term
trials comparing different training models are rare even in healthy adult populations
as reported by the American College of Sports Medicine position stand on the
recommended quantity and quality of exercise prescription in healthy adults
(American College of Sports Medicine, 1998b). Therefore, most of the studies
presented in this review which aim to elucidate training response for cancer patients
25

during and after treatment, were short in duration (Adamsen et al., 2003;
Cunningham, Morris, & Cheney, 1986; Dimeo, Rumberger, & Keul, 1998; Dimeo et
al., 2003; Dimeo, Tilman et al., 1997; Durak & Lilly, 1998; MacVicar, Winningham,
& Nickel, 1989; Na, Kim, Kim, Ha, & Yoon, 2000; Nieman et al., 1995; Porock,
Kristjanson, Tinnelly, Duke, & Blight, 2000; Schwartz, 1999; Schwartz, 2000;
Schwartz, Mori, Gao, Nail, & King, 2001; Segal et al., 2003; Segar et al., 1998;
Winningham & MacVicar, 1988; Winningham, M. L., M. G. MacVicar, M. Bondoc,
J. I. Anderson, & J. P. Minton, 1989) with some interventions still not controlling
elementary training variables (Durak & Lilly, 1998; Durak, Lilly, & Hackworth,
1999; Kolden et al., 2002; Mock, 2001b; Porock, Kristjanson, Tinnelly, Duke, &
Blight, 2000). The short-term nature of these interventions would likely limit the
ability to detect specific physiological responses with training. Moreover,
considering that exercise has been endorsed as a crucial component of a healthy
lifestyle and is viewed as a lifelong behaviour which may prevent and control various
disease conditions (Pate et al., 1995; Thompson et al., 2003; Wei, Gibbons, Kampert,
Nichaman, & Blair, 2000; Wei, M. et al., 1999), further studies undertaken for longer
periods of time are needed. Additionally, the specific training dose for this
population and how it would differentiate from many of the cancer types, treatments
modalities and stages of treatment remains an open area for prospective trials.
Despite the work by Segal and colleagues (2001) and Cunningham and associates
(1986) which compared a home based vs. supervised exercise and five- vs. three
times weekly resistance exercises, respectively, none of these studies had actually
used more than one training protocol, attempting to compare differences in training
response due to various intensities, frequencies, volume and type of training.
Consequently, a requirement for future studies on this topic should include
randomized controlled trials comparing how various types of cancer undergoing
different treatments and stages of the disease would respond to different training
stimuli.
Finally, the majority of the studies involving resistance training did not draw
on the wealth of scientific research which has been published in regard to resistance
training for muscle hypertrophy and strength gain. In all cases excepted one
(Adamsen et al., 2003) the intensity of exercise in particular was inferior to the 6-10
RM load that has been deemed optimal for muscle growth and strength enhancement
(Kraemer et al., 2002; Kraemer & Ratamess, 2004). One of the better designed
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resistance training interventions addressed in this review was by Cunningham and
associates (1986) and yet their model was based on research completed around 1950
(Delorme & Watkins, 1948; Delorme, West, & Shriber, 1950). Moreover, the only
study which incorporated a better-quality training intensity limited the program to 6weeks and performed no more than three resistance exercises (Adamsen et al., 2003).
Although much more research is required in this important area some guidelines and
possible physiological outcomes are provided in Table III. Future research into
exercise interventions with cancer patients should involve contemporary resistance
training program designs incorporating adequate intensity, periodization, selection of
functional exercises involving large muscle groups, and manipulation of rest period
and recovery strategies to maximize the anabolic effect on muscle and bone, as well
as positive endocrine responses.
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Table I. Experimental design exercise studies during cancer treatment.
Study
Cunningham
et al 1986
(49)

Duration/
Freq.
5 weeks
3-5 x week

Winningham
et al. 1988
(50)

12 weeks
3 x week

Winningham
et al. 1989
(48)

12 weeks
3 x week

Macvicar
et al. 1989
(30)
Mock
et al. 1997
(23)

10 weeks
3 x week
6 weeks
4-5 x week

n/ sex/ age

Type of cancer

Exercise program

Intensity

Leukemia

Resistance training

Unspecified

40, M, W
(14-44 y)
Cardiovascular
Cycling IT
20-30 minutes

60-85% MHR

Breast

Cardiovascular
Cycling IT
20-30 minutes

60-85% MHR

↑ Lean tissue mass
↓ 0.5% Body fat
↓ Skinfold sites

Breast

Cardiovascular
Cycling IT

60-85% MHR

↑ 42% VO2max

Breast

Cardiovascular
Walking
20-30 minutes

Self-paced

↑ 4% 12-MWT
↓ Fatigue
↓ Symptom experience

24, W
(45 y)

46, W
(35-64 y)

↓ Nitrogen balance
↔ Creatinine excretion
↔ AC
↓ Nausea

Breast
42, W
(45-48 y)

45, W
(43-46 y)

Outcome measures
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Dimeo
et al. 1997
(29)

~ 2 weeks
Daily

Dimeo
et al. 1998
(22)

6 weeks
5 x week

Dimeo
et al. 1999
(35)

*
Daily

Schwartz et al.
1999, 2000
(46, 47)

8 weeks
4 x week

Na
et al. 2000
(25)

2 weeks
5 x week

Schwartz
et al. 2001
(52)

8 weeks
3-4 x week

70, M, W
(39-40 y)
5, M, W
(18-55 y)

59, M, W
(40 y)

Breast, Sarcoma
Carcinoma
Adenocarcinoma
Neuroblastoma
Hodgkin’s lymp.
Non-Hodgkin’s lymp.
Bronchial, Breast
Medulloblastoma

Cardiovascular
Cycling IT
30 minutes

50% HRR

↓ 14% MP, ↓ Thro
↓ Neutro, ↓ Hosp

Progressive
treadmill Walking
30-35 minutes

3 mmol.L (LC)
80% MHR

↓ 100% LC
↓ 18% Heart rate
↑ 101 % TD
↑ 12 % MP

Breast, Lung
Carcinoma, Seminoma
Adenocarcinoma
Hodgkin’s lymp.

Cardiovascular
Cycling IT
30 minutes

50% HRR

↓ Psychologic distress

Breast

Cardiovascular
Walking
35 minutes

Self-paced
Accelerometers

↑ 10.4% 12-MWT
↓ Fatigue

Stomach

Cardiovascular
Arms and Cycling
Ergometers
30 minutes

60% MHR

↑ 28% NKCA

Breast

Cardiovascular
Walking
12 minutes

Self-paced
Accelerometers

↑ 15% 12-MWT
↓ Fatigue

27, W
(35-57 y)
35, *
(28-75 y)

72, W
(27-69 y)
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Mock
et al. 2001
(31)

6-24 weeks
5-6 x week

Segal
et al. 2001
(45)

26 weeks
5 x week

Kolden
et al. 2002
(24)

16 weeks
3 x week

Segal
et al. 2003
(32)

12 weeks
3 x week

Dimeo
et al. 2003
(26)

~ 2 weeks
Daily

Breast

Cardiovascular
Walking
10-30 minutes

Self-paced

↑ 6% 12-MWT
↓ Fatigue
↓ Emotional distress

Breast

Cardiovascular
Walking
Home vs. nonhome based

50-60%
VO2max

↑ Physical functioning
↔ Quality of life
↔ VO2max

Breast

Cardiovascular
Walking, Cycling,
Stepping
Resistance training
Flexibility

Unspecified

↑ 11% Flexibility
↑ 15.4% VO2max
↑ 34.5% UB
↑37% LB
↓ 5% RSBP
↑ Quality of life

Prostate

Resistance training
2 sets
12 repetitions

60-70% 1-RM

↑ 42% UB
↑ 36 % LB
↔ Body composition
↔ PSA, ↓ Fatigue
↑ Quality of life

Leukemia,
Hodgkin’s lymp.
Non-Hodgkin’s lymp.
Myeloma

Cardiovascular
Walking

70% MHR

↔ Walking speed
↓ 6.7% HEM

52, W
(28-75 y)

123, W
(51.4 y)

40, W
(45-76 y)

155, M
(68.2 y)

66, M, W
(20-73 y)
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Courneya
et al. 2003
(27)

16 weeks
3-5 x week

Adamsen
et al. 2003
(28)

6 weeks
4 x week

Colorectal

Cardiovascular
Walking
Flexibility

65-75% MHR

↔ Quality of life
↔ Cardiovascular
capacity

Leukemia , Breast
Colon, Ovary
Testis, Cervix
Hodgkin’s lymp.
Non-Hodgkin’s lymp.

Resistance training
3 sets
5-8 repetitions
Cardiovascular
Cycling
Relaxation

60-100% MHR
85-95% 1-RM

↑ 32.5% WB
↑ 16% VO2max
↔ Quality of life

102, M, W
(61.1 y)
23, M, W
(18-63 y)

↔ = no change, ↑ = increase, ↓ = decrease, W = women, M = men, * = not described, PSA = Prostate-specific antigen, LC = Lactate
concentration, VO2max = VO2 maximum, IT = Interval training, TD = Training distance, MHR = Maximum heart rate, MP = Maximal
performance (MET), HEM = Hemoglobin, AC = Arm circumference, UB = Upper body strength, LB= Lower body strength, WB = Whole
body strength, RSBP = Resting Systolic Blood Pressure, NKCA = Natural killer cell cytotoxic activity, HRR = Heart rate reserve,
Neutro = duration of neutropenia, Thro = duration of thrombopenia, Hosp = duration of hospitalization.
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Table II. Experimental design exercise studies after cancer treatment.
Study

Duration/
Freq.
12 weeks
2 x week

n/ sex/age

Peters et al.
1994, 1995
(39, 40)

28 weeks
2-5 x week

24 ,W
(49 y)

Nieman
et al. 1995
(43)

8 weeks
3 x week

12, W
(61 y)

Dimeo
et al. 1997
(36)

6 weeks
5 x week

36, M, W
(39-42 y)

Sharkey
et al. 1993
(38)

10, M, W
(19 y)

Type of cancer

Exercise program

Intensity

Outcome measures

Cardiovascular
*

60-80% MHR

10% ET, ↔ AT
↔ Peak OX
↔ Peak HR

Cardiovascular
Cycling

~ 60% MHR

↑↓ Satisfaction of life
↔ NKCA
↔ Leukocytes
↓ 2.1 % Lymphocytes
↓ 1.1% Monocytes
↑ 4.1% Granulocytes

Breast

Cardiovascular
Resistance raining

75% MHR

↔ NKCA
↔ LB
↑ 6-minute Walk Test

Non-Hodgkin’s lymp.
Breast, Sarcoma
Seminoma, Lung

Cardiovascular
Walking
30 minutes

3 mmol.L
(LC)

↑ 32% MP
↑ 30% HEM

Leukemia
Ewings Tumor
Neuroblastoma
Wilms’ Tumor
Rhabdomyosarcoma
Breast
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Segar
et al. 1998
(44)

10 weeks
4 x week

24, W
(30-65 y)

Breast

Cardiovascular
30-40 minutes

≥ 60% MHR

↓ Depression
↓ Anxiety

Durak
et al. 1998
(41)

10 weeks
2 week

20, M, W
(50 y)

Carcinoma,
Lymphoma
Leukemia

Cardiovascular
Resistance training
Flexibility

Own RPE

↑ 43% WB, 41.4%↑
MP
↑ Quality of life

Durak
et al. 1999
(42)

20 weeks
2 x week

25, M, W
(44-71 y)

Prostate
Carcinoma
Leukemia

Cardiovascular
Resistance training

Unspecified

↔ Aerobic capacity
↑ 45% WB

Porock
et al. 2000
(37)

4 weeks
*

9, M, W
(51-77 y)

Bowel, Breast, Oral,
Pancreas, Melanoma

Cardiovascular
Resistance training

Unspecified

↓ Depression ↓ Anxiety
↔ Fatigue

↔ = no change, ↑ = increase, ↓ = decrease, ↑↓ = increased at week 5 and decreased at post test, * = not described, M = men, W = women,
LC = Lactate concentration, MHR = Maximum heart rate, MP = Maximal performance (MET), HEM = Hemoglobin, LB = Lower body
strength, WB = Whole body Strength, NKCA = Natural killer cell cytotoxic activity, ET = Exercise tolerance, AT = Anaerobic threshold,
Peak OX = Peak oxygen uptake, Peak HR = Peak heart rate.
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Table III. Guidelines and possible physiological outcomes from exercise in cancer patients
Exercise Modality

Intensity

Frequency

Volume/ Dosage

Cancer Relevant Expected Outcomes

Cardiovascular
Exercises

55-90% MHR
40-85% MHRR

3-5 x per week

20-60 minutes
continuous or intermittent

↑ Cardiopulmonary function
↑ Insulin sensitivity*, ↑ HDL*, ↓ LDL*
↓ Fat mass, ↓ Fatigue

Anabolic/Resistance
Exercises

50-80% 1-RM
6-12RM

1-3 x per week

1-4 Sets per muscle group

↑ Muscle mass*, ↑ Muscle strength
↑ Muscle power*, ↑ Muscle endurance
↑ BMD*, ↑ FP, ↓ Fatigue
↑ Resting metabolic rate*, ↓ Fat mass*

Flexibility
Exercises

?

2-3 x per week

2-4 Sets per muscle group
10-30 seconds

↑ ↔ Range of motion

↑ = increase, ↓ = decrease, ↔ = maintain, MHR =maximum heart rate, MHRR = maximum heart rate reserve, HDL = high-density
lipoprotein, LDL = low-density lipoprotein, BMD = bone mineral density, FP = functional performance, RM = repetition maximum
* Data not available with cancer population, recommendation based from studies undertaken with non-cancer population.
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Chapter 3
REVIEW OF LITERATURE TWO

ANABOLIC RESPONSES TO RESISTANCE TRAINING
IN OLDER MEN AND WOMEN: A BRIEF REVIEW

Daniel A. Galvão, Robert U. Newton & Dennis R. Taaffe.
Journal of Aging and Physical Activity. 13:343-358, 2005.
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Introduction
Normal aging is characterized by a decline in skeletal muscle mass and an
increase in fat mass (Frontera et al., 2000; Fukagawa, Bandini, & Young, 1990;
Lexell, 1995). The reduction in muscle mass, termed sarcopenia, leads to a loss in
muscle strength and is associated with a decline in physical function that
compromises independent living (Rosenberg, 1997). However, numerous studies
have shown resistance training to be a safe and effective intervention to counteract
sarcopenia, even in very old persons, that is, those aged 85 years and older (Charette
et al., 1991a; Fiatarone et al., 1990; Fiatarone et al., 1994; Taaffe, Duret, Wheeler, &
Marcus, 1999; Taaffe, Pruitt, Pyka, Guido, & Marcus, 1996).
The landmark study in 1988 by Frontera and colleagues (Frontera, Meredith,
O'Reilly, Knuttgen, & Evans, 1988b), using computed tomography scanning of the
mid-thigh and muscle tissue samples, clearly showed the residual capacity that older
adults have to increase muscle cross-sectional area (CSA) with an increase in
midthigh total muscle area of 11.4% and an increase in type I and II fiber area of
33.5% and 27.6%, respectively, following 12 weeks strength training. Subsequently,
numerous studies have reported positive changes in muscle CSA, muscle fiber size,
and body composition following resistance training interventions (Charette et al.,
1991a; Fiatarone et al., 1990; Fiatarone et al., 1994; McCartney, Hicks, Martin, &
Webber, 1996a; Taaffe, Duret, Wheeler, & Marcus, 1999; Taaffe, Pruitt, Pyka,
Guido, & Marcus, 1996). Less clear is the effect of age and sex on the anabolic
response to resistive exercise.
In studies directly comparing anabolic responses between young and older
adults to resistance exercise, older adults retain the ability to adapt in a relatively
similar fashion to their younger counterparts (Hakkinen et al., 1998a; Ivey et al.,
2000; Lemmer et al., 2000; Roth et al., 2001), although this has not always been
reported (Welle, Totterman, & Thornton, 1996). Within young adults, the majority of
studies (Abe, DeHoyos, Pollock, & Garzarella, 2000; Cureton, Collins, Hill, &
McElhannon, 1988; Hurlbut et al., 2002; Lemmer et al., 2000; Lemmer et al., 2001;
O'Hagan, Sale, MacDougall, & Garner, 1995; Roth et al., 2001; Staron et al., 1994)
indicate that men and women experience similar relative changes in fat-free mass,
muscle CSA and fiber CSA after training, though others (Ivey et al., 2000) have

37

reported a greater response in men. In older adults (> 60 years), some investigations
have demonstrated similar relative strength gains and body composition changes
between men and women following training (Fiatarone et al., 1994; Ivey et al., 2000;
Lexell, 1995; McCartney, Hicks, Martin, & Webber, 1995, 1996a; Roth et al., 2001;
Tracy et al., 1999) while others indicate the presence of sex differences as
determined by single muscle fiber contractile function (Trappe et al., 2001), fiber
diameter (Bamman et al., 2003; Hakkinen et al., 2002) and muscle CSA (Hakkinen et
al., 1998b). It has been suggested that differences in anabolic hormones and the
myostatin genotype may contribute to these sex differences (Bamman et al., 2003;
Ivey et al., 2000).
Given the increased recognition of sarcopenia in the medical and allied health
community, and the recommendation by professional bodies for older adults to
undertake resistance exercise (American College of Sports Medicine, 1998b), the
effects of training in the older adult need to be clearly delineated, including any
differences by sex. Women are more susceptible to falling below the strength
thresholds required for daily activities and are subject to longer periods of
compromised function than men due to their greater longevity (Ivey et al., 2000). As
a result, if sex differences exist in the response to a given exercise stimulus, then this
needs to be determined so that the most appropriate exercise programs can be
devised. Therefore, the purpose of this paper is to present an overview of studies that
have undertaken measures of body composition, muscle and fiber CSA adaptations
to resistance training in older men and women who perform the same intervention. In
addition, we briefly discuss studies that include only older men or women to provide
a more comprehensive overview of the topic. Due to differences in tissue and body
composition techniques, this brief review is divided into seven sub-sections:
computed tomography, dual energy x-ray absorptiometry, magnetic resonance
imaging, compound ultrasound, the BOD POD, muscle biopsy, and myosin heavy
chain analysis.

Training Studies by Assessment Technique
An overview in chronological order of the studies directly comparing men and
women undertaking the same training intervention is provided in the accompanying
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table. Apart from the anabolic response, which is discussed below, the effect of the
intervention on body weight and muscle strength is also provided for the reader.

Computed Tomography (CT)
Computed tomography uses multiple x-rays and computers to reconstruct
images of the target area and generate quantitative information of muscle area,
subcutaneous and intermuscular fat area, and attenuation of the tissue as determined
by Hounsfield units (Lee, Wang, & Heymsfield, 2001; Mitsiopoulos et al., 1998;
Sipila & Suominen, 1993). McCartney et al. (1995) examined the effect of resistance
exercise on muscle CSA assessed by CT in men and women (60 to 80 years)
following 10 months training (Table). Subjects were randomly allocated to an
exercise or control group and performed the unilateral leg press, ankle plantar
flexion, ankle dorsi flexion, as well as several upper body exercises. Similar CSA
adaptation of the knee extensor muscles for men (6.2 %) and women (4.7 %) was
observed and both percentage changes were significantly greater than controls. In a
subsequent report following two years of training (McCartney et al., 1996), CSA of
the knee extensors for both men and women continued to increase, although not at
the same rate as that in the first year of the study.

Dual Energy X-ray Absorptiometry (DXA)
Dual energy x-ray absorptiometry estimates fat-mass, bone mineral-free lean
mass and bone mineral mass using two distinct low-energy x-rays that penetrate the
soft tissue and bone areas, and has been demonstrated to be an accurate and precise
method of body/tissue composition compared to reference methods such as total
body potassium, hydrodensitometry, magnetic resonance imaging (MRI), CT, and
four-component models (Haarbo, Gotfredsen, Hassager, & Christiansen, 1991;
Kohrt, 1998; Prior et al., 1997; Shih, Wang, Heo, Wang, & Heymsfield, 2000;
Visser, Fuerst, Lang, Salamone, & Harris, 1999). Body composition response to
resistance training assessed by DXA in older men and women was reported by
Martel et al. (1999). Subjects (65 to 73 years) trained three days per week for 24
weeks performing several upper and lower body exercises. There were no significant
differences as a result of resistance training in either sex for fat-free mass or body fat.
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When men and women were combined, a significant increase was detected for fatfree mass (p < 0.05).
Lemmer et al. (2000) reported the effect of a training regimen that
incorporated five sets of five repetitions maximum of unilateral leg extension
exercise of the dominant leg for nine weeks on strength and body composition in
older men and women. There was no significant change in body fat and fat-free
mass. Although the aim of the study was primarily designed to detect sex-related
changes on muscle strength with training and detraining, results from the body
composition changes are limited due to the fact that only the quadriceps muscle
group was trained. The same group of investigators (Lemmer et al., 2001) also
examined the effect of age and sex following 24 weeks resistance training. Eleven
men and 10 women (65 to 75 years) trained three days per week utilizing unilateral
leg press, leg curl, leg extension, chest press, lat pull down, military press, upper
back, triceps extension and unilateral biceps curl exercises. Men and women
significantly increased fat-free mass from baseline to week 24 (p < 0.05), with no
significant difference by sex.
Hurlbut et al.(2002) examined the effect of resistance training by age, sex and
angiotensin I-converting enzyme (ACE) genotype on fasting and glucose-stimulated
glucose and insulin response. Twelve men and nine women (65 to 75 years)
exercised thrice weekly over 24 weeks. The training routine consisted of three lower
body exercises, six upper body exercises and two trunk exercises. Following training,
men increased fat-free mass by 1.5 % (p < 0.05) and women by 2.2 % which
approached statistical significance (p = 0.06). There were no significant changes in
fat mass for either group.
Recently, Ryan et al. (2004) reported the results from a 24-week whole body
resistance training program on body composition in older men and women. There
was no significant change in fat-free mass for older women (1.7 %) whereas the
increase for older men (1.6 %) reached statistical significance (p < 0.05). No changes
were observed for body fat in either group. In addition, both men (24.2 %) and
women (20.8 %) similarly increased whole body muscle strength (p < 0.001), which
is the average strength for the exercises/muscle groups examined. Interestingly,
while percentage change in these studies (Hurlbut et al., 2002; Ryan et al., 2004) for
fat-free mass was similar between men and women, the latter group did not achieve
statistical significance perhaps indicating a greater within-group variance. That is,
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women may not demonstrate as consistent a change in response to resistance training
as men.

Magnetic Resonance Imaging (MRI)
In contrast to CT and DXA which employs ionizing radiation, MRI uses
magnetic energy and radio waves to derive images of a target tissue area and has
been found to be an accurate method for assessing tissue composition (Lee et al.,
2000; Lee, Wang, & Heymsfield, 2001; Mitsiopoulos et al., 1998). The effect of
resistance training on muscle volume assessed by MRI has been reported by Ivey et
al. (1999) and Tracy et al. (2000). Men and women (65 to 75 years) participated in a
resistance training intervention performing unilateral knee extension of the dominant
leg three times per week for nine weeks while the opposite leg served as the control.
Muscle volume change was similar for both men (11.5 %) and women (12 %), with
no change in whole body fat-free or fat mass assessed by DXA. The lack of change
in fat-free or fat mass assessed by DXA was not surprising given that only one
muscle group was trained.
Roth and colleagues (2001) examined sex differences in thigh muscle volume
response after resistance training in subjects aged 65 to 75 years. Nine men and 10
women performed unilateral leg press, unilateral leg curl, unilateral leg extension,
chest press, lat pull down, overhead shoulder press, upper back rowing, triceps
extension, and unilateral biceps curl exercises thrice weekly for 24 weeks. Both
groups demonstrated a significant increase in fat-free mass (p < 0.05) but not for
percentage of body fat assessed by DXA. MRI results indicated that both men (4.1
%) and women (5.8 %) increased (p < 0.01) estimated whole thigh muscle volume
with no significant difference between groups. Similarly, men (1.6 %) and women
(5.6 %) experienced a significant increase in mid-thigh muscle CSA (p < 0.01),
although the difference between sexes was not statistically significant.

Compound Ultrasonic Scanner (CUS)
Compound ultrasonic scanner uses acoustic impedance properties of the
body’s tissues to form an image from which muscle tissue can be separated from
bone and fat tissue (Sipila & Suominen, 1993). Hakkinen and colleagues (1998b)
41

investigated muscle strength, body composition and knee extensor cross-sectional
area by CUS of men and women (67 to 72 years) following 24 weeks of resistance
training. The program consisted of a combination of heavy resistance and explosive
training. Although percentage of body fat assessed by skinfolds did not change
during the course of the intervention, muscle CSA of the leg extensors increased by
5.8 % in women (p < 0.05) with no significant change for men (2.1 %).

BOD POD
The BOD POD estimates body composition by measuring the volume of air
an individual displaces inside an enclosed chamber and has been shown to be a valid
technique to estimate body composition (Fields, Goran, & McCrory, 2002; Fields,
Hunter, & Goran, 2000). Hunter and associates (2002) used a BOD POD to examine
the body composition response in older men and women after 25 weeks of resistance
training. Subjects performed five upper body exercises, two lower body exercises
and two trunk exercises three times per week during the intervention. Body fat
decreased (> 2 %) similarly and significantly for men and women (p < 0.05), while
the alterations in fat-free mass between men (4.7 %) and women (2.3 %) approached
significance (p = 0.06).

Muscle Biopsy
Muscle biopsy is a procedure in which muscle samples are extracted by the
needle technique, frozen and stored for histochemical analysis (Taaffe, Pruitt, Pyka,
Guido, & Marcus, 1996). The effect of resistance training on muscle strength and
type I and II muscle fiber CSA for the biceps brachii and the vastus lateralis muscles
of men and women (70 to 77 years) was examined by Lexell et al. (Lexell,
Downham, Larsson, Bruhn, & Morsing, 1995). Comparable mean gains in biceps
brachii type II CSA were found in men (17 %) and women (16 %), respectively.
However, this was not statistically significant in men due to the large inter-individual
variation. For the vastus lateralis muscle, there was no significant change in type I
and II CSA. However, type II CSA for men surprisingly decreased by 14 %.
Hakkinen and colleagues (2002) examined the effects of strength/power
training over 24 weeks on muscle fibre distribution and areas of type I, IIa and IIb
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CSA of the vastus lateralis in older men and women (60 to 75 years). Type I, IIa, and
IIb fiber area significantly increased by 50.6 %, 48.4 %, and 46.2 %, respectively, in
men with smaller, yet significant, changes in women of 28.6 % for type I and 33.2 %
for type IIa muscle fibers. However, the change in type IIb CSA for women of 18.9
% was not statistically significant. When comparing the results for these two groups,
this study demonstrated older men and women had the capacity to significantly
increase fiber CSA, with greater adaptations in men.
Bamman and associates (2003) reported the effects of 26 weeks of resistance
training on muscle fiber CSA and myosin heavy chain composition in nine men and
five women (61 to 77 years). Men and women similarly increased fat-free mass by
4.4 % and 4.2 %, respectively, and decreased body fat by 2.9 % and 3.1 % (p < 0.05)
as assessed by the BOD POD, with no significant difference by sex. However, results
from muscle biopsies indicated that men significantly increased muscle fiber type I,
IIa and IIx CSA by 29 %, 41 % and 43 % while women increased by only 6.5 %, 5.7
% and 5 %, respectively, indicating significant differences between the sexes. It is
important to note that only five women took part in the study and the number of
fibers analyzed was not reported. In addition, it is unclear if the investigators were
blinded to sex in the analysis. For clarification purposes, human type IIb fibers have
been shown to be homologous to the type IIx in the rat, therefore IIx is commonly
used for classification of this fiber type (Smerdu, Karsch-Mizrachi, Campione,
Leinwand, & Schiaffino, 1994). Apart from the small number of women taking part
in this study, it is possible that fiber size of the vastus lateralis muscle does not
reflect changes in other muscles following exercise (Frontera, Meredith, O'Reilly,
Knuttgen, & Evans, 1988b; Narici, Roi, Landoni, Minetti, & Cerretelli, 1989) and
sex differences in hypertrophy of other muscle groups could contribute to the similar
increase in whole body fat-free mass observed by Bamman et al. (2003).

Myosin Heavy Chain Expression (MHC)
Myosin heavy chain composition is analysed using a muscle sample extracted
using the muscle biopsy procedure followed by gel electrophoresis techniques for
protein separation (Frontera, Meredith, O'Reilly, Knuttgen, & Evans, 1988b;
Schiaffino et al., 1989). In addition, single muscle fibers may be isolated and the
characteristics both in terms of function and diameter. Such analysis has been
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completed by Trappe and associates (2001; Trappe et al., 2000) involving older men
and women following a resistance training program. In their first report (Trappe et
al., 2000), results from a 12-week leg extension program undertaken by older men
resulted in an increase (p < 0.05) of 20.4 and 12.7 % in the fiber diameter expressed
by MHC I and MHC IIa, respectively. Subsequently, the same group of investigators
reported the results from an identical training protocol, but on this occasion
undertaken by older women (Trappe et al., 2001). The fiber diameter expressed by
MHC I and MHC IIa increased in older women by 24.4 % (p < 0.05) and 6 %,
respectively. When the results from fiber diameter expressed by MHC I and MHC
IIa were compared, no sex differences were observed. However, single muscle fiber
function, expressed by absolute power and maximum shortening velocity, was
significantly greater in older men than women (p < 0.05). The authors suggested that
older men and women respond differently at the muscle cell level when the same
training stimulus is applied.

Discussion
As resistance training becomes increasingly recognized as an effective
countermeasure to sarcopenia in the medical community, and as more older adults
embark in these training regimens, the training responses including possible sex
differences need to be clearly identified. Moreover, from a research perspective, if
men and women attain similar relative anabolic and muscle strength changes to
training, then it is possible to combine both sexes in the same sample in exercise
trials to increase statistical power and/or facilitate subject recruitment.
Since the findings by Frontera and colleagues (1988b), which clearly refuted
Moritani & de Vries (1980) earlier report of a lack of soft-tissue change in response
to training in older men, numerous studies have demonstrated the residual capacity of
older adults to increase muscle and fiber cross-sectional area following resistance
training. Advances in the assessment of body and muscle composition by MRI, CT,
DXA and histochemistry over the past two decades have increased the ability to
detect subtle changes that were previously not possible.
Although studies directly comparing older women and men in their anabolic
adaptations to resistance training are somewhat limited (e.g., Bamman et al., 2003;
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Hakkinen et al., 2001; Lemmer et al., 2001; Roth et al., 2001), numerous studies
examined the effect of resistance training on fat-free mass, muscle and fiber area of
women and men undertaking different interventions (e.g. Charette et al., 1991;
Frontera et al., 1988; Taaffe et al., 1996) supporting the high level of adaptability
remaining in aging skeletal muscle.
The only study to date directly comparing muscle area in older men and
women by CT reported similar adaptations for the knee extensors of 6.2 % and 4.7
%, respectively (McCartney, Hicks, Martin, & Webber, 1995). The results for older
men are in agreement with results reported previously by the same laboratory
(Brown, McCartney, & Sale, 1990), where older men increased (p < 0.01) knee
extensor muscle CSA by 9.9% after 12 weeks of resistance training. Similarly,
Frontera et al. (1988b) reported comparable increases in knee extensor CSA in older
men assessed by CT (9.3 %) after 12 weeks training and Ferri and associates (2003)
reported an increase of 7.4 % in knee extensor muscle CSA following 16 weeks of
resistance training. Muscle CSA response to resistance training in older women has
been assessed by Sipila & Suominen (1995) using CT, with increases in knee
extensor CSA of 4.9 % after 18 weeks exercise, similar to those detected by
McCartney and colleagues (1995).
Studies directly comparing fat-free mass and fat mass by DXA (Hurlbut et
al., 2002; Ivey et al., 2000; Lemmer et al., 2000; Lemmer et al., 2001; Martel et al.,
1999; Roth et al., 2001; Tracy et al., 1999) following resistance training do not
support significant sex differences except for the study by Hurlbut and associates
(2002). It is important to point out that change in fat-free mass and fat mass were not
the main outcomes for these studies. As such, it is not expected that changes in body
composition will be detected with only one exercise even in a long-term intervention.
In such cases, sub-regional analysis of the DXA scan may have been a more sensitive
technique to detect local changes in tissue composition. In addition, the anabolic
effect of such isolated interventions is considerably compromised because the
endocrine responses favouring muscle hypertrophy will not be produced. For
example, elevation of testosterone and growth hormone with resistance training is
closely related to the volume of muscle activated (Hakkinen & Pakarinen, 1993;
Hakkinen, Pakarinen, Kraemer, Newton, & Alen, 2000; Kraemer et al., 1999a). In
contrast, Nichols and colleagues (1993) reported a significant increase in fat-free
mass of 3.6 % for older women in response to 24 weeks of whole body exercise. The
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percentage changes are comparable with those reported by Lemmer et al. (2001) of
2.1 % and Martel et al. (1999) of 2.4 % in women after the same duration and
frequency of training, although the changes observed by Martel et al. (1999) were not
statistically significant.
Several studies have compared men and women for muscle fiber CSA
adaptations to the same resistance training program. Interestingly, there are
conflicting findings among them. Lexell and colleagues (1995) reported similar
changes in men and women for the biceps brachii while Bamman and associates
(2003) demonstrated substantial increases in men with less magnitude changes in
women for the vastus lateralis muscle. Hakkinen et al. (2002) also reported that
relative hypertrophy was two-fold higher in type I and IIb fiber CSA for the vastus
lateralis muscle in men compared to women.
Comparing these two gender studies with those involving men or women
only also reveals conflicting outcomes. For example, the magnitude of change
observed in men by Bamman and associates is in agreement with Frontera et al.
(1988) who reported a 33.5 % and 27.6 % increase in type I and type II fiber crosssectional area in men. However, Brown and colleagues (1990) reported substantial
increases in both type I (13.7 %) and type II (30 %) biceps brachii muscle fiber CSA
in older men similar to Hakkinen and associates (2001) for the vastus lateralis muscle
in women (type I, 18 %; type IIa, 27.7 %; type IIb, 38 %) following 21 weeks
training. In addition, Charette et al. (1991a) reported an increase of 7.3 % and 20.1 %
for type I and II fiber CSA, respectively, after 12 weeks training, while Taaffe and
colleagues (1996) reported comparable increases in type I (27.5 %) and type II CSA
(22.1 %) following 52 weeks training in women.
The relatively small sample size in most of the studies presented in this
review likely limit the ability to detect statistically significant differences between
men and women and should be considered when interpreting the results from these
experiments. Moreover, large inter-individual variation to identical training protocols
increases the standard deviation of the samples and reduces the statistical power to
detect a difference if one exists. Some of the studies presented (Hunter, Bryan,
Wetzstein, Zuckerman, & Bamman, 2002; Martel et al., 1999; Roth et al., 2001;
Trappe et al., 2001) have a two-fold or greater increase in anabolic response between
men and women, yet are not significantly different. However, differences of this
magnitude may be clinically important. Therefore, clinical/practical versus statistical
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significance must be considered. Moreover, numerous studies presented in this
review were not specifically designed to examine anabolic differences by sex, having
such outcomes only as a secondary endpoint of the intervention. Thus, considering
the design limitations and differences in anabolic measurement techniques used in
previous studies, future research should incorporate larger sample sizes with multiple
measurement time points for anabolic responses.
In summary, the majority of studies directly examining anabolic responses to
resistance training in older men and women support comparable adaptations
following 9 to 42 weeks of exercise with similar relative increases in muscle
strength. However, two recent studies indicate that men may exhibit a greater
adaptation than women at the muscle cell level when undertaking the same training
program (Bamman et al., 2003; Hakkinen et al., 2002). Although, superior changes
in fiber CSA may occur in men, only the study by Bamman et al. (2003) indicates
that these anabolic changes translate into greater relative improvements in muscle
strength. Therefore, based on the studies conducted to date, it appears appropriate to
include older men and women in the same exercise regimen as the anabolic and
muscle strength response is relatively similar.
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Table. Older men vs. women anabolic response to resistance exercise.
Study

Lexell et al.
1995

McCartney
et al. 1995

Duration/
Freq./
Sets/ Rep./
Intensity

Subjects
(Sex, n, age)

Metho
d

Tissue/ Body Composition
% Change

Body
Weight
%
Change

Strength
% Change

Sex
Differenc
e

11 weeks
3 x week
3 sets/ 6 rep
85% 1RM

M (n = 6)
70-77y
W (n = 10)
70-77y

Biopsy

(BB) TI 13.0, TII 17.0
(VL) TI - 1.0, TII - 14.0 *
(BB) TI 13.0, TII 16.0 *
(VL) TI - 8.0, TII 1.0

n.r.

107.0 WB *

M=W

n.r.

104.0 WB *

42 weeks
2 x week
2-3 sets
10-12 rep
50-80%
1RM

M (n = 39)
60-80y
W (n = 37)
60-80y

CT

CSA (QF) 6.2 *

n.r.

36.7 WB ♦ *

CSA (QF) 4.7 *

n.r.

46.2 WB ♦ *

M=W
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Hakkinen
et al. 1998

Tracy et al.
1999

Martel et al.
1999

Ivey et al.
2000

24 weeks
2 x week
3-6 sets
3-15 rep
50-80%
1RM

M (n = 11)
72y
W (n = 10)
67y

CUS, S

9 weeks
3 x week
5 sets/5RM

M (n = 12)
65-75y
W (n = 11)
65-73y

MRI
DXA

24 weeks
3 x weeks
1-2 sets/
5RM

M ( n = 11)
65-73y
W ( n = 10)
65-73y

DXA

9 weeks
3 x week
5 sets/ 5RM

M (n = 12)
65-75y
W (n = 11)
65-75y

MRI
DXA

B.f. - 1.0, CSA (QF) 2.1

n.c.

21.3 LB *

B.f. n.c., CSA (QF) 5.8 *

n.c.

30.0 LB *

B.f. n.c., CSA (QF) 11.5 *

0.9

27.0 LB *

B.f. - 0.7, CSA (QF) 12.0 *

- 0.2

29.0 LB *

B.f. - 1.0, F.f.m. n.c.

2.4

21.9 WB *

B.f. - 1.0, F.f.m. 2.4

(n.c)

23.9 WB *

B.f. n.c., F.f.m. 0.7
MV (thigh) 11.5 *
B.f. - 0.7, F.f.m. -1.8
MV (thigh) 12.0 *

0.9 *

n.r.

- 0.2

n.r.
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W>M

M=W

M=W

M=W

Trappe et
al.
2000, 2001

12 weeks
3 x week
3 sets/ 10 rep
80% 1RM

M ( n = 7)
74y
W (n = 7)
74y

Biopsy

Roth et al.
2001

24 weeks
3 x week
1-2 sets/
5RM

M (n = 9)
65-75y
W (n = 10)
65-75y

DXA
MRI

9 weeks
3 x week
5 sets/ 5RM

M (n = 12)
65-75y
W (n = 11)
65-75y

DXA

24 weeks
3 x week
1-2 sets/
5RM

M (n = 11)
65-75y
W (n = 10)
65-75y

DXA

Lemmer
et al. 2000

Lemmer
et al. 2001

TI 20.4 * ,TIIa 12.7 *

(n.r)

50.0 LB *

TI 24.4 *,TIIa 6.0

(n.r)

56.0 LB *

B.f. - 1.0, F.f.m. 1.0 *
MV (thigh) 4.1 *
B.f. - 0.4, F.f.m. 2.1 *
MV (thigh) 5.8 *

- 0.7

14.5 WB *

1.7

21.7 WB *

B.f. n.c., F.f.m 1.7

1.2

27.0 LB *

B.f. - 1, F.f.m. 2.4

n.c.

29.0 LB *

B.f. - 0.9, F.m. - 2.8
F.f.m. 1.7 *
B.f. - 0.4, F.m. 1.0 **
F.f.m. 2.1 *

0.3

23.0 WB *

1.7

22.8 WB *
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M=W

M=W
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Hurlbut
et al. 2002

Hunter
et al. 2002

Hakkinen
et al. 2002

Bamman
et al. 2003

24 weeks
3 x week
1-2 sets
5RM

M (n = 12)
65-75y
W (n = 9)
65-75y

DXA

25 weeks
3 x week
2 sets
10RM

M (n = 14)
61-77y
W (n = 12)
61-77y

CT, BP

24 weeks
2 x week
2-4 sets
3-12RM

M (n = 10)
60-75y
W (n = 11)
60-75y

Biopsy
S

26 weeks
3 x week
2 sets
10RM
80% 1RM

M (n = 9)
61-77y
W (n = 5)
61-77y

Biopsy
BP

B.f. - 0.8, F.m. - 2.5
F.f.m. 1.5 *
B.f. - 0.6, F.m. n.c.
F.f.m. 2.1 **

0.1

23.8 WB *

1.5

22.4 WB *

B.f. - 2.7, F.m. - 9.1 *
F.f.m. 4.7 *
B.f. - 2.1, F.m. - 6.2 *
F.f.m. 2.3*

1.0

32.5 WB *

- 1.0

38.5 WB *

B.f. - 0.9 *, F.f.m. 0.9 *
TI 50.6 *†, TIIa 48.4 *†, TIIb 46.2
*†
B.f. - 0.8, F.f.m. - 0.4
TI 28.6 * , TIIa 33.2 * , TIIb 18.9

- 0.2

35.0 LB *

- 1.5

38.4 LB *

B.f. - 2.9 *, F.f.m. 4.4 *
TI 28.0 *†, TIIa 41.0*†, TIIx 42.0
*†
B.f. - 3.1 *, F.f.m. 4.2 *
TI 6.5 *, TIIa 5.7 *, TIIx 5.0 *

0.6

82.0 LB
*†
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- 0.8
52.0 LB *

M=W

M=W

M >W

M >
W

Brose et al.
2003

Ryan et al.
2004

14 weeks
3 x week
1-3 sets
10-12 rep
50-80%
1RM

M (n = 7)
68.3
W (n = 7)
69.9y

DXA
Biopsy

24 weeks
3 x week
1-2 sets
12-15RM

M (n = 10)
65-74y
W (n = 10)
65-74y

DXA

B.f. - 0.2, F.f.m. n.c.
TI 24.2 *, TIIa 24.6, TIIx 40.6*
B.f. - 0.9,F.f.m. 1.6
TI 5.3 *, TIIa 3.1, TIIx 17.0*

- 0.5

36.1 WB *

n.c.

46.0 WB *

B.f - 0.8, F.m. - 2.5
F.f.m. 1.6 *
B.f - 0.7, F.m. - 0.6
F.f.m. 1.7

0.2

24.2 WB *

0.7

20.8 WB *

M=W

M=W

* significantly different from baseline (P < 0.05) , ** approached significance compared to baseline (P = 0.06), † significantly different
between groups (P < 0.05), ‡ approached significance between group (P = 0.06), DXA = dual energy X-ray absorptiometry, CT =
computed tomography, BP = BOD POD, CUS = compound ultrasonic scanner, MRI = magnetic resonance image, S = skinfolds, CSA
= cross-sectional area, TI = type I CSA, TII = type II CSA, TIIa = type IIa CSA, TIIb = type IIb CSA, TIIx: = type IIx CSA, F.m.: =
fat mass, B.f. = % body fat, F.f.m. = fat free mass, MV = muscle volume, LB = lower body strength, WB = total body strength, QF =
quadriceps femoris, H = hamstrings, BB = biceps brachii, VL = vastus lateralis, n.c. = no change, n.r. = not reported, ♦ data taken
from graph.
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Chapter 4
EXPERIMENTAL STUDY ONE

CHANGES IN MUSCLE, FAT, AND BONE MASS AFTER
36 WEEKS OF MAXIMAL ANDROGEN BLOCKAGE
FOR PROSTATE CANCER

Manuscript submitted to British Journal Urology International May 2006
Daniel A. Galvão, Nigel A. Spry, Dennis R. Taaffe, Shannon T, Rowling C
& Robert U. Newton

Introduction
Prostate cancer is the fifth most common cancer representing 19% of cancers
among men in developed countries with more than 80% of the cases occurring in
men older than 65 years (Parkin, Bray, Ferlay, & Pisani, 2005; Parkin, Pisani, &
Ferlay, 1999). Traditional treatments for prostate cancer that focus on reducing the
levels of or effects of testosterone by Androgen Deprivation Therapy (ADT) may
lead to detrimental side effects in the musculoskeletal system (Diamond, Higano,
Smith, Guise, & Singer, 2004; Holzbeierlein, McLaughlin, & Thrasher, 2004;
Pickett, Bruner, Joseph, & Burggraf, 2000; Stege, 2000). Some of these side effects
are directly related to changes in body composition with an increase in fat mass and
reduction in muscle mass that may negatively impact physiological function
(Holzbeierlein, McLaughlin, & Thrasher, 2004; Sharifi, Gulley, & Dahut, 2005;
Smith, 2004; Smith et al., 2002). Moreover, these treatment side effects would
exacerbate the age-related loss of muscle mass, termed sarcopenia, further
compromising muscle strength, physical function and dependent living (Rosenberg,
1997). The simultaneous increase in fat mass during ADT can lead to increased
levels of total cholesterol and triglycerides (Sharifi, Gulley, & Dahut, 2005; Smith et
al., 2002; Tayek et al., 1990) and consequently the possible development of
cardiovascular complications (Holzbeierlein, McLaughlin, & Thrasher, 2004; Sharifi,
Gulley, & Dahut, 2005). Additionally, ADT has been associated with reduced bone
mass which can compromise bone strength and increase fracture risk (Diamond,
Higano, Smith, Guise, & Singer, 2004; Shahinian, Kuo, Freeman, & Goodwin, 2005;
Smith, 2002b; Smith et al., 2005) compounded by increased risk of falling
precipitated by the reduced muscle strength.
Only scant information on alterations to bone mass and soft-tissue following
ADT exist (Smith, 2004; Smith et al., 2002; Tayek et al., 1990), and there is no
information on changes in the regional distribution of bone, lean and fat mass (i.e.
trunk, upper, and lower limb) during therapy. Abdominal fat has been related to
increased risk for the development of cardiovascular complication, thus, if ADT
tends to induce greater trunk fat accumulation, alternative or adjuvant therapies
should be devised to counteract such conditions. Similarly, are losses in muscle and
bone mass greater at weight-bearing sites than non-weight bearing sites and can
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strategies be incorporated into the patient’s management plan to address this?
Moreover, these changes in body composition and tissue distribution can be directly
related to chronic conditions that result in disability and loss of independence in
older adults.
Considering that the life expectancy for prostate cancer patients has
increased, additional information on how bone mass and body composition adapts
during ADT seems relevant so that strategies to counter the physiological side effects
can be devised and recommended. The purpose of the present study was to examine
the alterations in whole body and regional bone, lean and fat mass in men that occurs
after receiving ADT for prostate cancer.

Methods
Subjects
Seventy-two prostate cancer patients aged 44 to 88 years receiving
intermittent androgen blockage had hip, spine and whole body scans by dual-energy
x-ray absorptiometry (DXA) performed at baseline and following 36 weeks of
treatment. The patients were a sub-group of those participating (n = 250) in a multicentre trial of ADT from 1999-2004, and were from the one clinical site. Subjects
were required to have a histological or cytological diagnosis of adenocarcinoma of
the prostate and to have an ECOG performance status of 0, 1 or 2 at baseline. Prior
neoadjuvant hormonal therapy did not preclude study entry provided that treatment
had been administered more than two years ago and given for no more than six
months. Institutional Ethics Committee approval was obtained and each participant
provided written consent. ADT was achieved by a maximal androgen deprivation
program employing Flutamide (Eulexin®) 250mg tid and Leuprolide (Lucrin®)
22.5mg three monthly depot during the course of 36 weeks. Disease extent was
prospectively categorised as: locally advanced disease without evidence of metastatic
disease but not considered suitable for or declining radical treatment; recurrent local
disease following radical prostatectomy, or radical radiotherapy and associated with
a rising PSA ≥ 2ng/mL, measured on three consecutive occasions, at intervals of at
least one month or more apart and without evidence of metastatic disease.
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Bone Mineral Density and Body composition
Bone mineral density (BMD, g/cm2) and content (BMC, g) of the total hip,
spine and whole body was assessed by DXA (Hologic Discovery W, Waltham, MA).
In addition, whole body bone mineral-free lean mass (LM) and fat mass (FM), upper
limb lean mass and fat mass (ULLM, ULFM), lower limb lean mass and fat mass
(LLLM, LLFM), trunk lean mass and fat mass (TrLM, TrFM) and percent body fat
were derived from the whole body scan. Regional analysis was derived by
manipulating segmental lines according to specific anatomic landmarks (Taaffe et
al., 2001; Taaffe, Lewis, & Marcus, 1994). A vertical line extended between the head
of the humerus and the glenoid fossa separated the upper limbs from the trunk, while
an oblique line through the femoral neck separated the lower limbs from the pelvis.
Upper limb and lower limb lean tissue mass represent the sum of left and right
extremities. ULLM and LLLM were then combined to derive appendicular skeletal
muscle (ASM) (Heymsfield et al., 1990; Wang et al., 1996).

PSA, Testosterone and Blood Counts
All measurements were performed on samples collect after overnight fasting.
PSA and free testosterone was measured by chemiluminescent microparticle
immunoassay (Architect I200SR, Abbott Diagnositics). Full blood counts were
determined using an automated blood counting (electrical impedance, Beckman
Coulter diagnostics).

Bone Markers
Serum osteocalcin was determined using radioimmunassay techniques as
previously described (Kent et al., 1990). Urine calcium, urine calcium excretion and
urine calcium / creatinine ratio were assessed using a Hitachi 917 chemistry analyser
and alkaline phosphatase using a Hitachi modular unit.

Height and Weight
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Height and weight were determined by a stadiometer and electronic scale,
respectively, and body mass index (BMI, kg/m2) was calculated from weight divided
by the square of height.

Physical activity and Fatigue
The European Organization for Research and Treatment of Cancer EORTC
QLQ-C30 version 2.0 core questionnaire quality of life (QOL) were used to assess
changes in physical activity and levels of fatigue. The QLQ-C30 core questionnaire
incorporates nine multi-item scales: five functional scales (physical, role, cognitive,
emotional, and social); three symptom scales (fatigue, pain, and nausea and
vomiting); and a global health and quality of life scale. Several single item symptom
measures were also included. All scales are scored from 0 to 100. High scores for a
functional scale represented high or healthy levels of functioning, and similarly for
global health or quality of life. High scores for a symptom scale or item represented
high levels of symptomatology or problem.

Statistical Analyses
Data were analyzed using the SPSS (Version 11.0, SPSS Inc., Chicago, IL)
statistical software package. Analyses included standard descriptive statistics and
paired two-tailed Student’s t-tests. To adjust for multiple comparisons, an alpha level
of 0.01 was set as the criterion for statistical significance. Results are given as the
mean ± SE.
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Results
Subject characteristics are shown in Table 1. The mean age of the participants
was 73.5 ± 1 year with a BMI of 27.1 ± 0.4 kg/m2. Levels of serum testosterone,
PSA and hemoglobin decreased (P < 0.001) by 93.3% ± 0.4, 98.2% ± 0.5%, and 8.8
± 0.9, respectively and markers of bone formation and resorption increased following
treatment (Table 2). Additionally, following treatment, physical activity levels
significantly decreased from 89.5 ± 2.3 to 83.5 ± 2.3 (P = 0.008) and fatigue
increased from 16.2 ± 2.0 to 26.8 ± 2.5 (P < 0.001).
Baseline and week 36 values as well as percent change for whole body and
regional lean, fat and bone mass are shown in Table 3. Following treatment, whole
body LM (1.4 ± 0.2 kg) and bone mass (61.5 ± 10.3 g) significantly (P < 0.001)
decreased and FM increased (2.2 ± 0.3 kg). There were significant (P < 0.01)
declines at all regional sites for LM, with the percent decline in LLLM and ULLM
greater than that for the TrLM (P = 0.004). Conversely, fat mass increased (P <
0.001) at all regional sites with the change in the limbs greater than the trunk (P <
0.001). There was a significant (P < 0.001) reduction in hip and spine BMD of 1.5 %
and 3.9 % respectively, and a decline in upper limb BMD of1.3% (P < 0.001) with
no significant change for lower limb BMD. The decrease in bone density at the spine
was greater than that at the hip site (P = 0.032).

Discussion
The results from the present study demonstrate that 36 weeks of ADT in men
with non-metastases prostate cancer has a deleterious effect on whole body and
regional tissue composition by decreasing muscle and bone mass and increasing fat
mass. The change in soft tissue was greater for the limbs than the trunk, and for the
older patients may contribute to a decline in their functional performance and loss of
independence.
Our findings confirm the changes in whole body composition previously
reported by Smith and associates (Smith et al., 2002) where body weight and fat
mass increased by 2.4% and 9.4%, respectively, and lean mass decreased by 2.7%
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following 48 weeks of ADT. Recently, the same group(Smith, 2004) reported an
increase of 11% in fat mass and a decrease of approximately 4% in lean mass after
one year of ADT. The present study extends these findings and indicates that the
decline in lean mass from the upper and lower limbs is greater than changes
occurring in the trunk. This preferential loss from the limbs would be expected given
that the trunk includes a large organ mass (which will not be affected by treatment)
in addition to skeletal muscle. As reduced muscle mass and function are directly
associated with impairments and compromised function in older adults (Bassey et al.,
1992; Evans, 1995), our findings would suggest that countermeasures need to be
implemented to maintain or even reverse the rate of muscle loss in the most affected
areas following ADT. Resistance training has been reliably shown to be a safe and
effective strategy to improve muscle mass and function in older adults (Taaffe, 2006)
including the very old (Fiatarone et al., 1990) and may play an important role in
attenuating or reversing this muscle loss in ADT treated men (Galvao & Newton,
2005).
We also observed an increase in fat accumulation at all regional sites with the
upper and lower limbs showing greater changes than for the trunk. The increase in
whole body fat is consistent with previous studies (Smith, 2004; Smith et al., 2002),
however, we note regional differences in fat distribution with ADT. Increased
abdominal fat mass has been associated with a greater risk for developing coronary
artery disease, type 2 diabetes, hyperlipidemia and premature death than accretion of
fat mass in the extremities (ACSM, 2000). Consequently, although the accumulation
of fat was relatively less for the trunk, strategies aimed at minimizing fat accretion
during ADT should be explored. In addition, the decline in lean mass would
negatively impact basal metabolic rate and hence energy requirement and this would
contribute to the increase in fat mass associated with ADT. Therefore, strategies
aimed at preserving lean mass will also assist in attenuating the increase in fat mass.
In the present study we also noted a significant decrease in lumbar spine and
hip BMD and reduction of whole body BMD following therapy. A number of studies
have reported decreases of bone mass following ADT (Diamond, Campbell, Bryant,
& Lynch, 1998; Eriksson, Eriksson, Stege, & Carlstrom, 1995; Maillefert et al.,
1999; Shahinian, Kuo, Freeman, & Goodwin, 2005) and recent reviews(Diamond,
Higano, Smith, Guise, & Singer, 2004; Holzbeierlein, McLaughlin, & Thrasher,
2004) have highlighted the importance of addressing bone loss and osteoporosis in
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this group of cancer patients. It is interesting that our analyses showed that although
BMD decreased in the upper limbs, these changes were not observed in the lower
limbs. The loading that the lower extremities are subject to may have contributed to
the preservation of bone density compared to the non-weightbearing upper
extremities. Additionally we also noted that BMD for the spine showed greater
reductions than at the hip. This may be attributed to the greater trabecular bone
composition of the spine compared to the proximal femur, where earlier bone
turnover and therefore loss of BMD in the axial skeleton may occur (Marcus, 1991).
Maillefert and colleagues (1999) have also reported greater losses in BMD at the
lumbar spine than femoral neck in a small group of patients following 18 months of
ADT. We observed in addition to the changes in BMD, a marked increase in markers
of bone resorption and formation indicating increased bone turnover.
In summary, we found that 36 weeks of ADT has a negative impact on whole
body and regional tissue composition in men with non-metastatic prostate cancer.
These changes were marked with reductions in lean mass and increases in fat mass
occurring at all regional sites (upper limbs, lower limbs and trunk). Additionally,
decreases in lumbar spine and hip BMD and whole body and upper limb BMD were
observed. We propose that strategies to counteract such changes in soft tissue and
bone mineral during ADT in older men should be implemented to minimize the risk
of sarcopenia, osteoporosis, and obesity, and subsequent disability.
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Table 1. Subjects Characteristics at Baseline (n = 72)

Age (yr)
Height (cm)
Weight (kg)
BMI (kg/m²)
Body fat (%)

(Mean ± SE)
73.5 ± 0.9
171.2 ± 0.7
79.6 ± 1.5
27.1 ± 0.4
25.5 ± 0.6

BMI = body mass index

61

Range
(44.4 to 88.4)
(154.5 to 186.8)
(55 to 116.3)
(18 to 38)
(9 to 36)

Table 2. Total testosterone, PSA, haemoglobin and bone markers changes following 36 weeks of Androgen Deprivation Therapy (Mean
± SE).
Baseline (n = 68)
15.1 ± 0.6
22.6 ± 3.1
145.2 ± 1.5

Total Testosterone (pg/ml)
PSA (ng/ml)
Hemoglobin (g/L)
Bone Markers
Serum Osteocalcin *
4.7 ± 0.05
Alkaline Phosphatase †
89.0 ± 6.1
Urine Calcium/Creatinine Ratio †
240.4 ± 24.6
Urine Calcium Excretion †
21.2 ± 2.4
PSA = prostate specific antigen, * n = 63, † n = 62.

36 weeks (n = 68)
0.80 ± 0.03
0.23 ± 0.05
131.9 ± 1.5

Percent change (%)
- 93.3 ± 0.3
-98.2 ± 0.5
-8.8 ± 0.9

P value
< 0.001
< 0.001
< 0.001

7.4 ± 0.7
99.5 ± 7.1
415.3 ± 39.11
35.3 ± 3.6

341.0 ± 111.2
13.5 ± 3.0
101.5 ± 12.2
94.0 ± 12.0

0.002
0.001
< 0.001
< 0.001
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Table 3. Body composition and bone mass changes following 36 weeks of Androgen Deprivation Therapy (Mean ± SE).
Lean tissue mass
LM (kg)
ULLM (kg)
LLLM (kg)
TrLM (kg)
ASM (kg)
Fat mass
FM (kg)
ULFM (kg)
LLFM (kg)
TrFM (kg)
Body fat (%)
Bone mass
TBBMD (g/cm2)
ULBMD (g/cm2)
LLBMD (g/cm2)
Total hip BMD (g/cm2) *
Spine BMD (g/cm2) *

Baseline (n = 68)

36 weeks (n = 68)

Percent change (%)

P value

55.8 ± 0.8
6.3 ± 0.1
17.1 ± 0.2
28.8 ± 0.4
23.4 ± 0.3

54.4 ± 0.8
5.9 ± 0.1
16.4 ± 0.2
28.3 ± 0.4
22.4 ± 0.3

-2.4
-5.6
-3.7
-1.4
-4.2

± 0.4
± 0.6
± 0.5
± 0.5
± 0.5

< 0.001
< 0.001
< 0.001
0.009
< 0.001

20.8 ± 0.7
2.1 ± 0.1
5.5 ± 0.2
12.13 ± 0.4
25.8 ± 0.6

23.1 ± 0.7
2.5± 0.1
6.4 ± 0.2
13.1 ± 0.4
28.5 ± 0.7

13.8 ± 2.3
20.7± 3.3
18.7 ± 2.7
12.0 ± 2.5
2.6 ± 0.3

< 0.001
< 0.001
< 0.001
< 0.001
< 0.001

1.164 ± 0.014
1.732 ± 0.015
2.576 ± 0.038
1.021 ± 0.018
1.123 ± 0.024

1.145 ± 0.014
1.708 ± 0.015
2.559 ± 0.041
1.001 ± 0.018
1.086 ± 0.023

-2.4 ± 0.3
-1.3 ± 0.3
-0.6 ± 0.4
-1.5 ± 0.5
-3.9 ± 0.4

< 0.001
< 0.001
0.173
< 0.001
< 0.001

LM = bone mineral-free lean mass, ASM = appendicular skeletal muscle, TrLM = trunk lean mass, ULLM = upper limb lean mass,
LLLM = lower limb lean mass, FM = fat mass, TrFM = trunk fat mass, ULFM = upper limb fat mass, LLFM = lower limb fat mass,
TBBMD = total body bone mineral density, ULBMD = upper limb bone mineral density, LLBMD = lower limb bone mineral
density, BMD = bone mineral density, * n = 69.
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EXPERIMENTAL STUDY TWO

RESISTANCE TRAINING AND REDUCTION OF PHYSICAL
TREATMENT SIDE EFFECTS IN PROSTATE CANCER
PATIENTS

Medicine Science in Sports and Exercise, In Press, May 2006
Daniel A. Galvão, Kazunori Nosaka, Dennis R. Taaffe, Nigel Spry, Linda J. Kristjanson,
Michael McGuigan, Katsuhiko Suzuki, Kanemitsu Yamaya, & Robert U. Newton

Resistance Training in Men Receiving ADT

Introduction
The use of androgen deprivation therapy (ADT) in the form of gonadotropin releasing
hormone (GnRH) agonists for prostate carcinoma increased extensively across all stages and
histologic grades of prostate cancer in the past decade (Cooperberg, Moul, & Carroll, 2005;
Shahinian, Kuo, Freeman, Orihuela, & Goodwin, 2005). However, the reduction in
testosterone levels by ADT is accompanied by a number of adverse side effects (Basaria et al.,
2002; Basaria, Muller, Carducci, Egan, & Dobs, 2006; Diamond, Higano, Smith, Guise, &
Singer, 2004; Shahinian, Kuo, Freeman, & Goodwin, 2005; Sharifi, Gulley, & Dahut, 2005;
Smith et al., 2001). Some of these side effects include reduction of muscle strength, lean and
bone mass, increased fat mass and risk of fracture, unfavorable lipid profile and depression
compromising physical and physiological function (Greenspan et al., 2005; Shahinian, Kuo,
Freeman, & Goodwin, 2005; Sharifi, Gulley, & Dahut, 2005; Smith, 2004; Stoch et al., 2001).
Importantly, these side effects are closely related to an increased risk of developing other
chronic conditions (Basaria, Muller, Carducci, Egan, & Dobs, 2006; Shahinian, Kuo,
Freeman, & Goodwin, 2005; Sharifi, Gulley, & Dahut, 2005). Increases of ~7-10% in fat
mass and decreases of ~ 2-4% in lean mass after one year of ADT have been reported in
recent studies (Greenspan et al., 2005; Lee, McGovern, Finkelstein, & Smith, 2005; Smith,
2004; Smith et al., 2002) as well as reduced muscle strength (Basaria et al., 2002).
Additionally, substantial decreases in trabecular and cortical bone mass have been found
following administration of ADT with a concomitant increased risk for fracture at multiple
skeletal sites (Shahinian, Kuo, Freeman, & Goodwin, 2005; Smith et al., 2005). As a result,
strategies to preserve body composition and improve physical function may reduce falls risk,
fracture, and subsequent complications.
Existing treatments to alleviate these side effects have been predominantly
pharmaceutical, however, these treatments are expensive, and their effects do not translate
into improved physical and functional capacity. To date, most of the experimental studies
examining the role of exercise during cancer treatments have included breast cancer patients
and aerobic exercise rather than resistance exercise (Courneya, 2003; Galvao & Newton,
2005). In view of the extensive scientific literature supporting resistance training as the most
effective exercise mode for improving muscle strength, physical function and counteracting
sarcopenia in older adults (Fiatarone et al., 1990; Frontera, Meredith, O'Reilly, Knuttgen, &
Evans, 1988a; Taaffe, 2006), resistance exercise may have a significant role in preventing the
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catabolic effects of ADT by promoting a sufficient anabolic environment which can lead to
positive musculoskeletal benefits and enhanced physical function.
Segal and associates (2003) recently reported positive changes in quality of life and
fatigue outcomes subsequent to a short-term resistance training program in prostate cancer
patients undertaking testosterone suppression. However, questions remain regarding the
adaptive response of specific physiological and physical parameters, such as body
composition, muscle hypertrophy, bone mineral density, functional performance and balance
in a longer-term trial in this population. We therefore designed a non-randomized clinical trial
to examine the possible effects of a 20-week high intensity progressive resistance training
program on muscle function, functional performance, balance, body composition and muscle
thickness in older men receiving ADT for prostate cancer.

Methods
Ninety-one prostate cancer patients, referred by oncologists and urologists or who
responded to advertisements via local newspaper and radio in the city of Perth, Western
Australia from February through July 2005, were initially screened for participation in the
study (Figure 1). Exclusion criteria included: no histologically documented prostate cancer,
not receiving ADT in the previous 2 months, not scheduled to receive ADT for the subsequent
6 months, metastatic disease, any musculoskeletal, cardiovascular, or neurological disorder
that could inhibit them from exercising, inability to walk 400 m or undertake upper and lower
limb exercise, resistance training in the previous 12 months, and unwillingness to undertake
20 weeks of resistance training. Eleven men were eligible and invited for familiarization
sessions. One subject withdrew from the study at week seven because of an acute respiratory
infection that resulted in several weeks of hospitalization (Figure 1). Prior to participation, all
subjects obtained medical clearance from their physician and completed a health history
questionnaire. Regarding the activity levels of the subjects prior entering the intervention,
seven men were not undertaking any form of structured exercise, one was a regular walker,
one a regular walker and jogger, and lastly, one was a recreational bowling player. The study
was approved by the university Human Research Ethics Committee and all subjects provided
written informed consent.
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Training Program
Ten subjects undertook 20 weeks of high-intensity progressive resistance training
twice a week for 20 weeks. The initial 10 weeks provided an introductory resistance exercise
phase consisting of hydraulic resistance training machines (Isotronic, Fitness Technology,
Australia) that are simple and time efficient to use, and provide exclusively concentric muscle
contractions likely to facilitate training initiation in this clinical group of men. The exercises
included the chest press, seated row, shoulder press, lat pull down, triceps extension, biceps
curl, leg press, squat, leg extension, leg curl, abdominal crunch and back extension exercises.
In the following 10 weeks, the training program was altered to isotonic resistance which
provides concentric and eccentric muscle contractions using similar exercises on different
apparatus (Cybex, Strength Equipment, USA). During this period, the lat pull down and
shoulder press exercises were alternated with the biceps curl and triceps extension exercises
every other session to maintain an exercise session length of 1 hour. In every session, general
flexibility exercises as well as one set for the first upper and lower body exercise at a lower
training intensity were undertaken to ensure adequate warm-up before the training program.
Both training phases were designed to progress from 12 to 6-repetition maximum (RM) for 2
to 4 sets per exercise. Briefly, both training phases were designed as weeks 1-2 (2 sets of 12RM), weeks 3-4 (3 sets of 10-RM), weeks 5-7 (3 sets of 8-RM) and weeks 8-10 (4 sets of 6RM) and were based on the American College of Sports Medicine position stand on
progression models in resistance training for healthy adults (Kraemer et al., 2002). All
sessions were conducted in small groups of 1-4 participants under direct supervision to ensure
safety, proper intensity and appropriate exercise technique. Additionally, all participants
recorded their training weights, number of repetitions and sets performed in an individual
exercise log to ensure adequate progression.

Muscle Function
Measures of muscle function included dynamic isotonic muscle strength and
endurance and were assessed at baseline, week 10 and week 20.
Dynamic Isotonic Muscle Strength
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Participants underwent two familiarization sessions that included instruction regarding
correct exercise technique and practice performing 2 sets of 12 repetitions on all hydraulic
resistance machines in addition to the chest press, seated row and leg press isotonic resistance
machines before muscle strength was determined. Dynamic isotonic muscle strength for the
chest press, seated row and leg press were measured using 1-RM, as described previously
(Taaffe, Duret, Wheeler, & Marcus, 1999). The 1-RM is the maximal weight an individual
can move through a full range of motion by maintaining proper exercise technique and not
changing body position other than that of the specific exercise motion.
The coefficient of variation in our laboratory for repeated 1-RM measures performed
approximately 1 week apart is 2.2% to 7.5%.
Dynamic Isotonic Muscle Endurance
Muscle endurance was measured using the maximal number of repetitions performed
at 70% of 1-RM for the chest press and leg press exercises (Galvao & Taaffe, 2005). For
week 10 and week 20 assessments, the baseline and either the week 10 or final 1-RM value,
respectively, was used to determine the resistance. The coefficients of variation performed
approximately 1 week apart for the chest press and leg press muscle endurance are 6.3% and
6.8%, respectively.

Physical Performance
A battery of tests was used to assess functional performance at baseline, week 10 and
week 20. Tests were performed in triplicate (except for the 400-m walk) with sufficient
recovery time between trials (Galvao & Taaffe, 2005). The fastest time recorded was used in
the analyses

Chair Rise to Standing
Subjects were seated in a hard-backed chair, with a seat height of 43 cm from the
floor, with their arms folded across their chest. They were instructed to rise as fast as possible
to a full standing position then return to a full sitting position 5 times(Galvao & Taaffe, 2005;
Taaffe, Duret, Wheeler, & Marcus, 1999). The coefficient of variation in our laboratory for
the repeated chair rise is 5.6%.
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6-Meter Walk
Two measures of gait speed were undertaken: usual pace, in which subjects were
instructed to walk at a pace similar to which they may use during common daily events; and a
fast pace (Fiatarone et al., 1990). Time taken was determined using 2 timing gates (Swift
Performance Equipment, NSW, Australia). The coefficients of variation in our laboratory for
usual and fast walk are 5.6% and 6.7%, respectively.
6-Meter Backwards Walk
As a measure of dynamic balance, subjects walked backwards 6 meters placing one
foot directly behind the heel of the other with the shoes touching (Fiatarone et al., 1990;
Taaffe, Duret, Wheeler, & Marcus, 1999). Time taken was assessed using timing gates.
Subjects were spotted by an investigator and if they deviated from the line (lost their balance),
they were instructed to move back to the line and continue the test, which increased the time
required. The coefficient of variation in our laboratory for the backward walk is 9.4%.
Stair Climb
Subjects were instructed to climb a flight of stairs (13 stairs per flight, 17 cm rise per
stair) as rapidly as they could safely manage without use of the handrails (Galvao & Taaffe,
2005). Two subjects required use of the handrails to perform this test. The coefficient of
variation in our laboratory for the stair climbing is 4.8%.
400-Meter Walk
For the test of walking endurance, participants were required to walk 400 meters,
which consisted of 10 laps out and back over a 20-meter course, as fast as they could at a pace
they could maintain over the distance (Galvao & Taaffe, 2005; Taaffe et al., 2003). The
coefficient of variation in our laboratory for the 400 meters walk is 2.5%.

Sensory Organization Test
The sensory organization test (SOT) was measured using the Neurocom Smart
Balance Master (Neurocom International Inc., USA). SOT consists of averaging three
equilibrium scores for six trial conditions. Subjects stood on the Neurocom force plate
without socks or any footwear and with a security belt attached (in case of a fall). According
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to the manufacturer’s protocol and previous studies (Wallmann, 2001) subjects undertook
three 20-second trials for each of the following conditions: 1) Eyes open, fixed support
surface and surround (visual, vestibular, and somatosensory input); 2) Eyes closed, fixed
support surface and surround (absent of visual input); 3) Eyes open, fixed support surface and
sway-referenced surround (visual input imprecise); 4) Eyes open, fixed surround and sway
referenced support surface (somatosensory inputs imprecise); 5) Eyes closed, fixed surround
and sway referenced support surface (somatosensory inputs imprecise and absent of visual
input); and 6) Eyes open, sway-referenced support surface and surround (imprecise
somatosensory and visual inputs). The Equilibrium score was reported as a value between 0
and 100, with 0 indicating a large sway and loss of balance, and 100 indicating perfect
stability. The coefficient of variation for the SOT is 1.5%.

Body Composition and Bone Mineral Density
Bone mineral density (BMD, g/cm2) of the hip (femoral neck, trochanter and Ward’s
triangle) and total body bone mineral content (BMC, g) was assessed by dual energy X-ray
absorptiometry (DXA, Norland XR-36, Wisconsin, USA). In addition, bone mineral-free lean
mass (LM), fat mass (FM), and percent fat were derived from the whole body scan. The
whole body scan was performed at baseline, week 10 and week 20, while the hip scan was
performed at baseline and week 20. Coefficients of variation in our laboratory (duplicate
scans with repositioning) for body composition components are less than 1.0%.

Muscle Thickness
Muscle thickness was assessed using B-mode ultrasound (Aloka, SSD-500, Tokyo,
Japan) at four anatomical sites [anterior (biceps brachii) and posterior (triceps brachii) upper
arm at 60% distal between the lateral epicondyle of the humerus and the acromial process of
the scapula; anterior (vastus lateralis and rectus femoris) and posterior (biceps femoris) thigh
at 70% thigh length between the greater trochanter and lateral condyle of the femur] similar to
the methods described previously by Abe et al (Abe, DeHoyos, Pollock, & Garzarella, 2000).
A 5-MHz scanning probe coated with a water soluble gel was placed on the skin
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perpendicular to the tissue interface. The subject was seated during the upper limb
measurement with the elbow extended and relaxed and in a standing position during the lower
limb measurement with the knee extended and relaxed. The muscle thickness measurement
was extracted from the ultrasonic image, with the distance between the subcutaneous adipose
tissue muscle-interface to the muscle-bone interface taken as muscle thickness (Abe,
DeHoyos, Pollock, & Garzarella, 2000). Two muscle thickness measurements were obtained
at each of the four sites and averaged to attain the final value. Great care was taken marking
the skin via anthropometric techniques, and printed images of baseline measures were
available during the week 10 and 20 repeated measurements to ensure identical sites were
assessed.
The coefficient of variation for muscle thickness using repeated ultrasound images in our
laboratory is less than 3.5%.

Blood Sampling
Venous blood samples were drawn from a forearm vein at a fixed time (8:30 AM 10:00 AM) at baseline, week 10, and week 20 into sterile vacutainers containing K2-EDTA
and serum separation tubes (Becton Dickinson,
Franklin Lakes, NJ, USA). The blood corrected by K2-EDTA tube was used for the
measurement of hemoglobin concentration by an automatic full blood counts analyser
(Sysmex XE-AlphaN, Sysmex Corporation, Kobe, Japan). The serum separation tubes was
left at room temperature for the blood to clot, and centrifuged for 10 min at 3000 rpm at 4oC.
The serum samples were stored in 0.7mL aliquots at –80oC until the day of analysis for
prostate specific antigen (PSA), free testosterone, growth hormone, and cortisol
concentrations.

Analysis of PSA, Serum Hormones and Hemolobin
PSA was measured by an Immurise analyser (Beckman Coulter Inc., Fullerton, CA.
USA) using a test kit (Diagnostic Products Corporation, Los Angeles, CA, USA). Serum
concentrations of the hormones were determined by RIA using a test kit (free testosterone:
DPC free testosterone kit, Diagnostic Products Corporation, Los Angeles, CA, USA; growth
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hormone: GH Kit, SRL Co., Tokyo, Japan; cortisol: Cortisol Kit, Immunotech, Beckman
Coulter Inc., Praque, Czeck Republic).

Statistical Analyses
Data were analysed using the SPSS (Version 11.0, SPSS Inc, Chicago, IL) statistical
software package and included standard descriptive statistics, analysis of variance (ANOVA)
and covariance (ANCOVA). Repeated measures ANOVA was used to compare subjects over
the three time-points, and ANCOVA was used to compare responses at week 20, adjusted for
the baseline value, between acute (< 12 months) and chronic (> 12 months) users of ADT.
Where appropriate, the Fisher Protected LSD test was employed to locate the source of
significant differences. An alpha level of 0.05 was required for significance and results are
given as the mean ± SD. The statistical power to detect change in the primary study outcomes
(physical and functional performance) over the 20-week intervention ranged from 0.75 to 1.0.

Results
Subject characteristics are shown in Table 1. All men were receiving ADT before
entry to the study with a mean duration of 1135 ± 1360 days. Six men were on GnRH
agonists, four men were on maximal blockage therapy (GnRH agonists + antiandrogens), and
one was on antiandrogens. Five men were on acute (initiating ADT within the last 12 months,
mean 156 ± 97days) and the remaining six were on chronic (receiving ADT for 12 months or
longer, mean 1951 ± 1391 days ) ADT. All subjects were treated with ADT during the entire
course of the study (including pre-, mid- and post-test measures and for all 40 training
sessions) over a 6-month period.

Dynamic Muscle Strength and Muscle Endurance
Baseline, week 10, week 20 and percentage change in muscle strength and endurance
values are reported in Table 2. There was a significant increase in strength for all three
exercises with a continuous improvement for both upper and lower body strength from
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baseline to week 10 and week 20 (p<0.001). Similarly, upper and lower body muscle
endurance (number of repetitions performed) increased (p<0.001) when 70% of the1-RM
baseline load was used during retesting. Muscle endurance assessed using 70% of the1-RM
post-test load also increased (p =0.024) for the leg press exercise and approached significance
(p=0.085) for the chest press.

Physical Performance and Sensory Organization Test
After the 20-week training period, there was a significant improvement (p<0.05) in the
chair rise, 6-m usual walk speed, backward walk speed, 400-m corridor walk, and stair
climbing test (Table 3). Additionally, the change in the chair rise, stair climbing, 6-m usual
walk and 400-m walk time was significantly different between baseline and week 10. There
was also a significant increase in the SOT equilibrium score (p=0.042).

Body Composition and Bone Mineral Density
There was no change for LM, FM, percent body fat, whole body BMC, or hip BMD
(Table 4), however, quadriceps muscle thickness increased by 15.7 ± 12.1 % (p=0.050). There
were no significant differences between acute (< 12 months) and chronic users of ADT for the
outcome variables (data not shown).

Serum Hormones and PSA
After the 10- and 20-week training period, there were no changes for free testosterone,
total testosterone, GH, cortisol and PSA (Table 5). It should be noted that one subject (Table
1) initiated the study with a relatively high PSA level and experienced a subsequent drop in
this marker during the intervention. Excluding this subject from the analyses resulted in PSA
values of 0.94 ± 1.4 ng/ml, 0.92 ± 1.2 ng/ml, and 0.86 ± 1.2 ng/ml (p = 0.945) at baseline,
week 10, and week 20, respectively.

73

Discussion
This is the first study to comprehensively examine the effects of high intensity
progressive resistance training on muscle function, functional performance, balance, body
composition and muscle thickness in men receiving ADT for prostate cancer. Substantial
improvements in muscle strength and endurance, as well as muscle thickness resulted while
body composition and bone mass were preserved during the 20-week intervention.
Importantly, these changes were accompanied by enhancement in several measures of
functional performance and balance. These results suggest that high intensity resistance
exercise can be safely tolerated in this group of men receiving ADT and enhanced muscle and
physical function ensues despite a compromised hormonal profile. These findings extend
those reported by Segal et al.(Segal et al., 2003) who found an increased quality of life and
decreased fatigue in men on ADT following 12 weeks resistance training, and provides a
rationale for why these benefits were observed.
In the present study, we found significant increases in muscle strength of 40 to 96%,
which are comparable to the effects of this exercise mode in healthy older adults not on ADT
(Galvao, Newton, & Taaffe, 2005). These observed changes are likely to be mediated by
nonhypertrophy –related factors such as neural adaptations to resistance training as previously
described (Sale, 1988). We also assessed the effects of training on muscle endurance, an
important neuromuscular parameter that has received only modest attention in exercise studies
(Galvao & Taaffe, 2005), and observed considerable improvement for both the upper and
lower body, especially when the baseline load was used during retesting. Similar
enhancement of muscle endurance using a comparable exercise intervention in communitydwelling healthy older adults not on ADT has been previously reported (Galvao & Taaffe,
2005) and indicates that older adults, including those on ADT, may accomplish daily tasks
more easily and with less fatigue following training . The combined results of increased
muscle strength and endurance in the present study could partially explain the reduced levels
of fatigue observed in the study by Segal et al. (Segal et al., 2003).
Changes in several functional performance measures were also observed in our cohort
of men, and these changes are comparable to previous studies in healthy older adults
undertaking resistance training (Galvao & Taaffe, 2005; Taaffe, Duret, Wheeler, & Marcus,
1999). Our results are particularly important as it implies a greater reserve capacity, and also
that daily activities can be more easily performed by using a lower percentage of maximal
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strength and endurance, thereby promoting enhanced independence. In addition, balance was
improved following training. The SOT equilibrium score has previously been used to discern
fallers from non-fallers in healthy older adults (Wallmann, 2001). Skeletal fracture risk is now
recognized as a major side effect from GnRH agonist treatment (Shahinian, Kuo, Freeman, &
Goodwin, 2005; Smith et al., 2005) and a relationship between the number of GnRH doses
received during the initial twelve months after diagnosis and subsequent risk for fracture has
been reported (Shahinian, Kuo, Freeman, & Goodwin, 2005). Our findings of improved
functional performance and balance following an exercise program could markedly contribute
to a reduction in falls and hence a reduced fracture risk during GnRH administration.
A large reduction in lean and bone mass and an increase in body fat are well
established side effects from ADT (Diamond, Higano, Smith, Guise, & Singer, 2004;
Greenspan et al., 2005; Lee, McGovern, Finkelstein, & Smith, 2005; Shahinian, Kuo,
Freeman, & Goodwin, 2005; Sharifi, Gulley, & Dahut, 2005; Smith et al., 2005). Importantly,
it has been suggested that these negative changes in soft tissue are more severe in the first
twelve months of ADT (Greenspan et al., 2005). In the present study, whole body lean mass,
fat mass and BMC, in addition to hip BMD, were preserved irrespective of acute or chronic
ADT exposure. This is an important outcome as these well known detrimental changes in the
muscular and skeletal system are closely related to other chronic conditions (Shahinian, Kuo,
Freeman, & Goodwin, 2005; Sharifi, Gulley, & Dahut, 2005; Smith et al., 2005) that can
compromise independence, possibly affecting mortality. In addition to whole body soft tissue,
we also examined local changes in skeletal muscle (targeted by the exercises) assessed by
ultrasound. Interestingly, quadriceps thickness increased by 15% despite a severely reduced
anabolic hormone environment.
Serum testosterone and PSA did not change during the study indicating that this
exercise mode can safely be undertaken in prostate cancer patients on ADT without
compromising the therapy purpose of reduced androgen levels. The lack of change in
testosterone and PSA is consistent with the only other published study in the area of resistance
exercise and prostate cancer (Segal et al., 2003). Further, GH, which could mediate resistance
training induced adaptations, did not change as a result of the intervention. Additionally, we
found that hemoglobin was also unaltered in our cohort which may also provide a basis for
Segal et al. (Segal et al., 2003) findings on reduced levels of fatigue following training.
Anaemia has been reported as one ADT-related side effect with reductions in hemoglobin
ranging from ~7-30% following therapy (Smith, 2004; Smith et al., 2002; Strum, McDermed,
Scholz, Johnson, & Tisman, 1997). The maintenance of hemoglobin levels in our group of
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men following 20 weeks of exercise, as well as the enhancement in muscle strength and
endurance, provides a likely mechanism for the prevention of fatigue in resistance trained
men on ADT.
Several limitations of the trial are worthy of comment. Although all subjects were
undertaking ADT during the course of the study, duration of use varied. However, we found
similar responses in training adaptations irrespective of acute or chronic ADT exposure,
possibly due to the low number of subjects in the sub-analysis. In addition, a randomized
controlled trial would have been a stronger experimental design. However, it is likely that a
control group after six months on ADT would have decreased in the study parameters and, as
such, differences in the exercise group would appear even more substantial. It is important to
point out that during the recruitment phase, all men reported that they would not have
complied with a 20-week control period if allocated to a control group suggesting that future
exercise trials should attempt to use alternative control exercise groups (e.g. cardiovascular,
flexibility training) as a strategy to enhance long-term exercise study designs. Nevertheless,
our study employed a comprehensive battery of measures to assess muscle and physical
function, as well as balance, and DXA and compound ultrasound to study change in soft
tissue. Lastly, our subjects were well-functioning individuals mostly motivated to undertake
the training program and may not be representative of all older men undertaking ADT for
prostate cancer.
In summary, the present study indicates that resistance exercise has beneficial effects
on muscle strength, functional performance and balance in older men receiving ADT for
prostate cancer and should be considered for preserving body composition and reducing
musculoskeletal side effects. Randomized controlled trials are warranted to confirm these
findings, and future studies are possible including multi-site. Further, behavioural oncology
groups committed to conducting behavioural interventions to assist the recruitment of larger
study groups would be desirable. Finally, longer exercise periods (>5 months) and training
during intermittent regimens of ADT are yet to be examined.
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Figure1. Recruitment and Flow of Participants Through the Exercise Study

91 subjects were contacted

55 prostate cancer survivors
responded to local radio and
newspaper advertisements

36 prostate cancer survivors
were referred by oncologist
and urologist

Excluded (n=49)
Not on ADT (n=21)
Off ADT within next 5 months (n=14)
Metastatic disease (n=5)
GP not approved participation (n=3)
Current undertaking resistance t. (n=3)
Too Busy (n=2)
No histological documented pc (n=1)

Dropped out due
to a minor stroke
(n=1)

Excluded (n=29)
Off ADT before 5 months (n=16)
Not interested (n=6)
Unable to train for 20 weeks (n=3)
GP not approved participation (n=2)
Too Busy (n=2)

Eligible for
participation
(n=6)

Eligible for
participation
(n=7)

Excluded due to
neurological
disorder (n=1)

Undertook baseline
measures (n=11)

Dropped out due to a severe
respiratory infection (n=1)

Completed 20 weeks of training (n=10)
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Table 1. Subjects Baseline Characteristic
Subject

Age
(years)

Diagnosis
(days)

ADT
(days)

Free
Testosterone
(pg/ml)

PSA
(ng/ml)

Weight
(kg)

BMI
(kg/m2)

Type of ADT

1

79

336

65*

0.79

20.30

66.9

24.3

LHRHa+A

2

65

92

88*

0.26

0.83

73.0

26.8

LHRHa

3

72

184

120*

7.99

1.20

96.7

31.9

LHRHa

4

66

363

210*

0.35

0.04

97.3

32.1

LHRHa

5

59

365

300*

0.15

0.03

68.1

21.2

LHRHa+A

6

72

732

420†

0.87

0.05

75.8

26.2

LHRHa

7

62

2520

720†

9.96

0.04

88.6

29.9

A

8

82

1821

1622†

0.65

2.70

69.9

24.2

LHRHa

9

63

3605

3240†

0.37

3.60

85.6

28.5

LHRHa+A

10

73

3960

3955†

0.35

11.80

76.8

28.0

LHRHa+A

Min

59

92

65

0.15

0.04

66.9

21.2

-

Max

82

3960

3955

9.96

20.30

97.3

32.1

-

Mean

70.3

1397.8

1135.6

2.13

3.09

80.2

27.4

-

SD

8.3

1481.8

1360.4

3.64

6.58

10.9

3.3

-
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BMI = body mass index, LHRHa = luteinizing hormone-realizing hormone agonist,
A = antiandrogen, * = acute ADT, † = chronic ADT
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Table 2. Muscle Strength and Endurance at Baseline and Following 10 and 20 Weeks Resistance Training (Mean ± SD).
Variable

Percentage

Baseline

Week 10

Week 20

Chest press 1-RM (kg)

30.9 ± 13.2

39.5 ± 15.4a

43.0 ± 16.4b,c

40.5 ± 18.5

<0.001

Seated Row 1-RM (kg)

36.4 ± 7.3

44.6 ± 7.3a

50.7 ± 7.6b,c

41.9 ± 21.4

<0.001

Leg press 1-RM (kg)

81.3 ± 34.2

109.0 ± 37.0a

158.0 ± 63.1b,c

96.3 ± 25.7

<0.001

Chest press end. (rep)

9.0 ± 2.5

13.8 ± 2.2a

20.2 ± 5.5b,c

114.9 ± 42.6

<0.001

Chest press end.†(rep)

9.0 ± 2.5

7.3 ± 2.2

9.4 ± 2.0

3.2 ± 31.7

0.085

Leg press end. (rep)

20.3 ± 7.9

35.8 ± 10.8a

47.2 ± 10.5b

167.1 ± 143.6

<0.001

Leg press end.†(rep)

20.3 ± 7.9

25.0 ± 8.4

27.2 ± 8.6b

56.3 ± 94.5

0.024

change

P value

Significant difference, P < 0.05, abaseline to week 10, bbaseline to week 20, cweek 10 to week 20.
1-RM = one repetition maximal, end. = muscle endurance at baseline test 70% of 1-RM, end. † = muscle endurance at post test 70% of 1RM, rep = number of repetitions performed.
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Table 3. Functional Performance Measures and Sensory Organization Test (SOT) at Baseline and Following 10 and 20 Weeks Resistance
Training (Mean ± SD).
Variable

Percentage

Baseline

Week 10

Week 20

Chair rise (s)

15.4 ± 4.9

11.3 ± 3.5a

10.5 ± 2.7b

-26.8 ± 7.1

<0.001

6-m backwards walk (s)

23.5 ± 9.3

18.7 ± 10.1

17.7 ± 10.1b

-22.3 ± 21.9

0.017

6-m usual walk (s)

5.0 ± 1.0

4.5 ± 0.8a

4.3 ± 0.7b

-14.1 ± 10.2

0.002

6-m fast walk (s)

3.7 ± 0.7

3.5 ± 0.7

3.5 ± 0.7

-5.5 ± 10.4

0.227

252.1 ± 46.5b,c

-7.4 ± 5.9

0.003

-10.4 ± 9.8

0.014

7.8 ± 6.9

0.042

400-m walk (s)

283.1 ± 60.0

255.6 ± 40.8a

Stair climb (s)

7.0 ± 3.6

6.5 ± 3.9a

6.3 ± 2.9b

SOT (0-100)

68.7 ± 8.3

72.7 ± 6.1

75.7 ± 6.9b

Significant difference, P < 0.05, abaseline to week 10, bbaseline to week 20, cweek 10 to week 20.
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P value

Table 4. Body Composition, Whole Body Bone Mass, Hip BMD and Muscle Thickness at Baseline and Following 10 and 20 Weeks
Resistance Training (Mean ± SD).
Variable

b

Percentage

Baseline

Week 10

Week 20

Bone mineral-free lean mass (kg)

52.2 ± 5.6

52.2 ± 5.8

52.0 ± 5.7

-0.4 ± 2.2

0.844

Fat mass (kg)

25.7 ± 8.5

25.0 ± 8.5

24.9 ± 8.4

-0.0 ± 6.1

0.823

Percentage body fat

30.7 ± 7.2

30.5 ± 6.7

30.6 ± 6.7

0.3 ± 5.3

0.852

Total BMC (g)

3055.5 ± 396.4

3073.1 ± 430.7

3063.2 ± 410.2

0.2 ± 2.5

0.763

Fem neck BMD (g/cm2)

0.868 ± 0.123

-

0.880 ± 0.115

1.6 ± 5.3

0.422

Trochanter BMD (g/cm2)

0.817 ± 0.110

-

0.820 ± 0.124

0.3 ± 4.7

0.806

Wards triangle BMD (g/cm2)

0.590 ± 0.124

-

0.596 ± 0.145

0.8 ± 7.0

0.751

Biceps thickness (cm)

2.69 ± 0.54

2.83 ± 0.43

2.91 ± 0.57

3.5 ± 6.9

0.621

Triceps thickness (cm)

1.94 ± 0.26

2.22 ± 0.51

2.33 ± 0.49

5.5 ± 17.0

0.875

Quadriceps thickness (cm)

2.15 ± 0.30

2.24 ± 0.42

2.46 ± 0.41b

15.7 ± 12.1

0.050

Hamstrings thickness (cm)

4.52 ± 0.74

4.31 ± 0.99

4.53 ± 0.89

0.2 ± 10.0

0.483

Baseline to week 20, P < 0.05.
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Table 5. Prostate Specific Antigen (PSA), Testosterone, Growth Hormone (GH), Cortisol, and Hemoglobin Following 10 and 20 Weeks of
Resistance Training (Mean ± SD).
Baseline

Week 10

Week 20

* p value

PSA (ng/ml)

3.09 ± 6.58

1.28 ± 1.58

0.90 ± 1.13

0.374

Free Testosterone (pg/ml)

2.13 ± 3.64

2.15 ± 3.61

1.56 ± 3.68

0.532

GH (ng/ml)

0.72 ± 0.75

0.83 ± 0.78

0.48 ± 0.37

0.239

Cortisol (ng/ml)

10.63 ± 3.54

10.35 ± 3.32

10.42 ± 2.67

0.979

Hemoglobin (g/L)

141.3 ± 13.1

142.3 ± 14.4

141.2 ± 13.5

0.913

* ANOVA (baseline, week 10 and 20)
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Chapter 6
CONCLUSIONS AND IMPLICATIONS
FOR FUTURE RESEARCH
This chapter summarizes the findings from the literature reviews and
experimental studies presented in the previous chapters and highlights future areas of
research that are warranted in the field of exercise and prostate cancer.
In literature review 1 (chapter 2), 26 published studies undertaken during and
after cancer therapy are summarized. The review provides an outline of exercise
studies and benefits derived during and after cancer therapy and is presented by
specific exercise modes as cardiovascular, resistance and flexibility training. The
majority of studies examined the effect of cardiovascular exercise, and breast cancer
was the most common cancer type examined. Only scant information on exercise
during prostate cancer therapy exists as just one trial examined the effect of
resistance training on rates of fatigue, health-related quality of life and muscle
strength in prostate cancer patients undertaking ADT. Although more research is
required in this important area we have provided some guidelines and possible
physiological outcomes from specific exercise modes. Consequently, future studies
should examine the beneficial role that exercise may have in various cancer patient
populations, and during various treatments and stages of the disease.
In literature review 2 (chapter 3) resistance exercise induced anabolic
adaptations in older men and women were examined by summarizing 16 studies.
Comprehensive information regarding resistance training as an exercise modality in
an aging non-cancer population is provided with a range of different assessment
techniques used among studies examining anabolic adaptations following training. It
is clear that resistance training is the most effective exercise mode to reduce the agerelated loss of muscle mass and strength and the capacity to adapt with age is
preserved. Emphasis on the effects of these adaptations between older men and
women responses is discussed. As such, the majority of studies directly examining
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anabolic responses to resistance training in older men and women support
comparable responses following 9 to 42 weeks of exercise with similar relative
increases in muscle strength. A number of specific assessment techniques undertaken
in studies with healthy older adults were in our experimental studies (e.g. DXA,
Ultrasound, 1-RM).
In experiment 1 (chapter 4) we investigated the effects of 36 weeks of
maximal androgen blockage in 72 prostate cancer patients on regional body
composition changes, bone mass, hemoglobin and bone markers. Seventy-two
prostate cancer patients receiving intermittent androgen blockage undertook hip,
spine and whole body scans by DXA performed at baseline and following 36 weeks
of treatment. We found that 36 weeks of ADT has a negative impact on whole body
and regional tissue composition in men with localized prostate cancer. These changes
were marked with reductions in lean mass and increases in fat mass occurring at all
regional sites (upper limbs, lower limbs and trunk). Additionally, decreases in
lumbar spine and hip BMD and whole body and upper limb BMD were observed.
Further, we observed in addition to the changes in BMD, a marked increase in
markers of bone resorption and formation indicating increased bone turnover. As
such, we suggested that strategies to counteract such changes in soft tissue and bone
mineral during ADT in older men are essential to minimize the risk of sarcopenia,
osteoporosis, and obesity, and subsequent disability. These findings in addition to
other recent studies in the area (Greenspan et al., 2005; Sharifi, Gulley, & Dahut,
2005) creates an important rationale to experiment 2 where the effects of a 20-week
progressive resistance exercise program in men on established ADT for prostate
cancer is examined.
In experimental study 2 (chapter 5), the effects of a progressive 20-week
resistance program on the physical, physiological and morphological responses in
prostate cancer patients receiving ADT was investigated. As reviewed in Chapter
two (review of literature 1) to date only one study (Segal et al., 2003) has been
published in the area of resistance exercise and ADT treated men for prostate cancer.
The study by Segal and colleagues (2003) indicated positive effects in terms of
decreased levels of fatigue and increased quality of life, however specific physical,
functional and physiological outcomes were not determined in their 12-week study.
Therefore, the primary aim of experiment 2 was to extend these findings by
examining as the effects of resistance exercise on muscle function, function
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performance, balance, body composition, muscle thickness and hemoglobin levels in
ADT treated men. As such, we conducted a non-randomized clinical trial where 91
potential subjects were initially screened with 11 subjects meeting the criteria to
entry the study and 10 subjects completing 40 exercise sessions and study measures
during the course of six months. As presented in chapter 5, the results indicated that
resistance exercise has beneficial effects on muscle function, functional performance
and balance in older men receiving ADT for prostate cancer. Further, body
composition was preserved during the 6-month intervention period and quadriceps
muscle thickness was increased. These findings extend those reported by Segal et al.
(2003) that found an increased quality of life and decreased fatigue in men on ADT
following 12 weeks resistance training, and provides a rationale for why these
benefits were observed. Moreover, our findings indicate that high intensity resistance
training can be safety implemented as part as adjuvant therapy for prostate cancer
patients on ADT as markers of the disease (PSA) and the therapy goal of testosterone
suppression were unaltered during intervention. These results also support and
extends those by Segal and colleagues (2003) who found that PSA and testosterone
did not change following a shorter training intervention undertaken at lower intensity
and volume.
Although our study employed a comprehensive battery of measures to assess
muscle and physical function, and blood markers, a randomized controlled trial
would have been a better study design and are warranted to confirm these findings.
However, as mentioned in Chapter 5, during the recruitment phase all men reported
that they would not have complied with a 5-month control period if allocated to a
control group suggesting that future exercise trials should attempt to use alternative
control exercise groups (e.g. cardiovascular, flexibility) as a strategy to enhance
long-term exercise compliance. Importantly, because we had rigorous inclusion
criteria including all participants already on ADT, different to the study by Segal et
al. (2003) where subjects were on ADT or were scheduled to initiate ADT for 12
weeks, we are certain that this affected our sample number. Nevertheless, this
criterion used ensured that all participants in the study were on ADT at least 2
months before initiating training. This fact not just extends the findings of Segal et
al. (2003) but makes our study unique in the way that all men were on least two
months on ADT treated prior to baseline measures. In addition, we noted that
intermittent regimens of ADT (Bhandari, Crook, & Hussain, 2005) are being
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extensively used in major hospitals in the city of Perth, where recruitment was
undertaken. Thus, in this specific regimen of therapy patients go “on” and “off”
therapy, and most of the time the “on” therapy phase was insufficient to fit with our
20-week exercise intervention and the time for all measures undertaken (6 months
study duration) affecting our recruitment.
Future studies are required including multi-site interventions involving
behavioural oncology groups committed to conducting behavioural interventions to
assist recruitment of larger study groups would be highly desirable. Further, longer
exercise periods (>5 months) and training during intermittent regimens of ADT are
yet to be examined. Lastly, a requirement for studies examining the impact of
different exercise modes, intensities and dosages of training in prostate cancer
patients undergoing different treatments and stages of the disease are yet to be
determined and should be considered in future clinical trials.
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APPENDIX I - RESISTANCE EXERCISE IN MEN RECEIVING
ADT FOR PROSTATE CANCER

1. I have read and understood the ‘Information Sheet’ for this study.
2. The nature and possible effects of the study have been explained to me.
3. I understand that the study involves the following procedures:
a. I will be required to obtain my doctors approval to undertake the study before
any measures or training can take place.
b. I will be required to either immediately undertake a resistance training
program for 20 weeks or to be part of a delay exercise group that will
undertake the exercise program after the first 20 weeks of intervention.
c. I will be required to have my height, weight, body composition, blood
analysis (PSA, hormones, immune system assessment) muscle thickness and
bone density taken before, at week 10 and after the study.
d. I will be required to complete a medical history before the training program
commences and a quality of life and fatigue and demographic questionnaire
both before and after the training/non-training period.
e. I understand that my muscle strength will be assessed before, during and after
the training period.
f. I understand that the following measures of physical function: the time to
climb a flight of stairs, the time it takes to walk backwards 6 meters, the time
it takes to rise from a chair and to walk 400 meters and my balance ability
will be assessed before and after 10 and the 20-week training/non-training
period.
4

I understand that all research data will be treated as confidential.

5

Any questions that I have asked have been answered to my satisfaction.

6

I agree to participate in this study and understand that I can withdraw at any
time without prejudice.

7

I agree that research data gathered for the study may be published provided
that I cannot be identified as a subject.
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This study has been approved by Human Research Ethics Committee at Edith Cowan
University contact number, should there be any concerns relating to the project, is
(08) 6304 2170 or Email: research.ethics@ecu.edu.au.
Name of subject (please Print)
______________________________________________
Signed ______________________________Date ___________________
Contact Phone Number
____________________________________________________
Witness (Name, please print)
________________________________________________
Signed _______________________________Date ___________________
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APPENDIX II - MEDICAL DOCTOR CONSENT FORM
Medical Doctor Consent Form for Resistance Training Study
“Resistance Exercise in Men Receiving ADT for Prostate Cancer”
Researchers:

Mr. Daniel Galvão, MSc, E-mail: d.galvao@ecu.edu.au Phone:

Professor Robert Newton, PhD

E-mail: r.newton@ecu.edu.au

Professor Linda Kristjanson, PhD

E-mail: l.kristjanson@ecu.edu.au

Dr. Michael McGuigan, PhD

E-mail: m.mcguigan@ecu.edu.au

Dr. Nigel Spry, MBBS, Radiation Oncologist

School of Biomedical and Sports Science, Edith Cowan University
Dear Doctor,
The School of Biomedical and Sports Science, Edith Cowan University is
undertaking a study into the effects of the dosage of resistance training in older
adults undertaking ADT (Androgen Deprivation Therapy) for prostate cancer. The
intervention program will run for 20 weeks, entailing high-intensity progressive
resistance (strength/weight) training for both the upper and lower body. Resistance
training has been shown to be a safe and effective method for enhancing muscle
strength in older adults, including the very old (JAMA, 263(22), 1990). Recently,
Segal and colleagues (J Clin Oncol, 21(9), 2003) reported positive physiological and
psychological benefits from this exercise modality in prostate cancer patients
undertaking ADT. We require sixty prostate cancer patients with at least 8 weeks
past initiation of ADT with non-bone metastases and no musculo-skeletal or
cardiovascular disorder that could inhibit them from exercising. Participants will be
randomly assigned to one of three groups: (1) low dosage group (1-2 sets of 4-12
repetitions at approximately 60 to 85 % of their maximal strength); (2) high dosage
group (2-4 sets of 4-12 repetitions at approximately 60 to 85 % of their maximal
strength); and (3) a delay exercise group, who will undertake testing but not
participate in training program during the first 20 weeks period. The exercise and
major muscles used in the intervention will be:
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1. Chest Press: Pectorals, Deltoid, Triceps Brachii
2. Seated Rows: Rhomboids, Latisimus Dorsi, Biceps Brachii
3. Biceps curl: Biceps Brachii, Brachialis
4. Triceps extension: Triceps Brachii
5. Leg Press: Quadriceps, Gluteals, Hamstrings
6. Squat machine: Quadriceps, Gluteals, Hamstrings
7. Leg Curls: Hamstrings
8. Leg Extensions: Quadriceps
Exercise sessions will commence with a 10-minute warm-up of aerobic activity and
stretching and conclude with a 10-minute cool-down period that includes exercises
for the abdominal (e.g. abdominal curls) and lower back area (e.g. single leg raises)
and stretching. The exercise sessions will be undertaken in the Conditioning
Laboratory in School of Biomedical and Sports Science, Edith Cowan University
using hydraulic and traditional resistance training machines to ensure participant
safety. All sessions will be conducted in small groups of up to 6 participants under
direct supervision by the principal investigators to ensure proper technique and
minimize the risk for injury. The total time to complete the exercise session will be
less than 60 minutes.
Outcome measures in the study include muscle strength and endurance, body
composition, muscle thickness (non-invasive ultrasound) hip and spine bone density,
endocrine responses, immunological responses, PSA levels and functional abilities
(e.g. 400-metre walk, balance test, time to rise from a chair), all standard measures in
studies of older adults.
Participants must meet the following criteria to participate: (Please, check boxes if
applied)
1) Undertaking ADT for at least 8 weeks: 
2) Non-bone metastases: 
3) No musculo-skeletal or cardiovascular disorder that could inhibit them from
exercising: 
The study has been approved by Human Research Ethics Committee at Edith Cowan
University subjects will be free to withdraw from the study at any time.
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The concern of the principle investigators are of past and/or present medical
conditions that may compromise the individual’s ability to participate in the
intervention, whether they be musculo-skeletal, neurological, cardiovascular, etc. in
origin. For these reasons all potential participants have been asked to seek their
medical doctor approval prior to involvement in the study.
Should you require further information, please feel free to contact us by phone or by
e-mail.

Sincerely,
Daniel Galvão and Robert Newton
_____________________________is in sufficient health to participate in the above
intervention study.
(Participant)
___________________________________________________________________
(Doctor’s signature)

(Date)
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APPENDIX III - SUMMARY PARTICIPANTS INFORMATION
SHEET

Resistance Exercise Dosage in Men Receiving ADT for
Prostate Cancer
Researchers: Mr. Daniel Galvão, MSc

E-mail: d.galvao@ecu.edu.au

Professor Robert Newton, PhD

E-mail: r.newton@ecu.edu.au

Professor Linda Kristjanson, PhD E-mail: l.kristjanson@ecu.edu.au
Dr. Michael McGuigan, PhD

E-mail: m.mcguigan@ecu.edu.au

Dr. Nigel Spry, MBBS, Radiation Oncologist
Contact Telephone number:

School of Biomedical and Sports Science, Edith Cowan University
Participant Information Sheet
SUMMARY
Purpose of the Study: To examine the effects of resistance training or weight
training on weight gain, loss of muscle and bone mass, tiredness, immune system and
quality of life in men with prostate cancer.
Subject Involvement: We require 60 prostate cancer patients undertaking treatment
to suppress male hormones to participate in this 20-week exercise study. Individuals
will be required to have non-bone metastases and no musculo-skeletal or
cardiovascular disorder that could prevent them from exercising, and not to have
participated in any weight training in the previous 12 months. In addition, volunteers
will be required to obtain consent from their doctor before participating in the study.
Intervention: Participants will be placed in one of two groups (by chance): immediate
exercise or delayed exercise group. Training groups will undertake twice weekly
supervised training sessions for 20 weeks. The delayed exercise group will
participate in the tests, and receive all information resulting from them, but not
exercise during the first 20 weeks of the intervention. A subsequent training program
will be provided for the delayed exercise group.
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Test Measures: Before starting the training, after 10 and 20 weeks participants will
be asked to take part in some tests to measure their strength, muscle characteristics
and abilities to take part in activities (i.e. rise from chair, walk 400 meters). Also
samples of blood will be obtained to assess relevant characteristics. In addition,
participants will be asked to complete some brief questionnaires about their quality
of life and abilities to take part in activities of daily living.
PARTICIPATION IS VOLUNTARY AND SUBJECTS ARE FREE TO WITHDRAW
FROM THIS STUDY AT ANY TIME.

The study has been approved by Human Research Ethics Committee at Edith Cowan
University subjects will be free to withdraw from the study at any time. Contact
number, should there be any concerns relating to the project, is (08) 6304 2170 or
Email: research.ethics@ecu.edu.au.
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APPENDIX IV - PARTICIPANT INFORMATION SHEET

Resistance Exercise Dosage in Men Receiving ADT for
Prostate Cancer
Researchers: Mr. Daniel Galvão, MSc

E-mail: d.galvao@ecu.edu.au

Professor Robert Newton, PhD

E-mail: r.newton@ecu.edu.au

Professor Linda Kristjanson, PhD E-mail: l.kristjanson@ecu.edu.au
Dr. Michael McGuigan, PhD

E-mail: m.mcguigan@ecu.edu.au

Dr. Nigel Spry, MBBS, Radiation Oncologist
Contact Telephone number: Daniel Galvão

School of Biomedical and Sports Science, Edith Cowan University
Participant Information Sheet
Purpose of the Study
The usual treatments for prostate cancer may have side effects. Some of these side
effects include weight gain, loss of muscle and bone mass, tiredness which may
affect a person’s quality of life. However, exercise has been shown to be a safe and
effective method for strength development in older adults. Recently, resistance
exercise has also been shown to safely increase muscle strength, quality of life and
decrease tiredness in men with prostate cancer. However, the effect of resistance
exercise on weight gain, muscle and bone mass and the immune system in this cancer
group is unknown. Therefore, the purpose of this present study is to examine the
effects of resistance training on weight gain, loss of muscle and bone mass, tiredness,
immune system and quality of life in men with prostate cancer. The findings from
this study will allow health professionals to plan exercise and the correct amount of
exercise for men with prostate cancer to help decrease side effects and improve their
quality of life
Subject Involvement
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We require 60 prostate cancer patients undertaking treatment to suppress male
hormones for at least six weeks to participate in this 20-week exercise study.
Individuals will be required to have non-bone metastases and no musculo-skeletal or
cardiovascular disorder that could inhibit them from exercising, and not to have
participated in any weight training in the previous 12 months. In addition, volunteers
will be required to obtain consent from their doctor before participating in the study.
In study 1, participants will be randomly allocated (by chance) to one of two groups:
immediate exercise or delay exercise group. In study 2, subjects from the immediate
exercise group (study 1) will be randomly allocated to two different training
protocols: low or traditional training dosage while the delay exercise group will
remain in a non-exercise condition. Training groups will undertake twice weekly
training for 10 weeks (study 1) with subsequent 10 more weeks (study 2) comprising
20 weeks of intervention. The delay exercise group will participate in the tests, and
receive all information resulting from them, but not exercise during the first 20
weeks of the intervention. A subsequent training program based from the outcome
measures from the first 20 weeks will be provided for the delay exercise group.
Training protocol
Twice weekly exercise sessions will commence with a 10-minute warm-up
comprising of low-level activity such as walking and stationary cycling, as well as
stretching.
Eight exercises that target the major upper and lower body muscle groups will be
performed using hydraulic resistance machines during the first 10 weeks of training
(Study 1).The exercises are: Chest Press/Seated Row, Biceps curl/Triceps extension,
Leg Press, Shoulder press/ Lat pull down, Squats, Leg Extension/Leg Curls, Upper
rower/ Dips, Abdominal/ Back extension.
Ten exercises that target the major upper and lower body muscle groups will be
performed using traditional resistance machines in the last 10 weeks of training
(study 2). The exercises are: Chest Press, Seated Row, Biceps curl, Triceps
extension, Leg Press, Shoulder press, Lat pull down, Leg Extension, Leg Curls, and
Abdominal.
Exercise sessions will conclude with a 10-minute cool-down that includes exercises
for the abdominal and lower back area and stretching. The exercise sessions will take
place in the Strength and Conditioning Laboratory, School of Biomedical and Sports
Science, at Edith Cowan University, using hydraulic weight training machines (study
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1) and traditional weight training machines (study 2) to ensure participants safety.
All sessions will be conducted in small groups of up to 6-8 participants under direct
supervision by the principal investigator to ensure proper technique and minimize the
risk for injury. The total time to complete the exercise session is less than 60
minutes. All participants will be asked to maintain customary physical activity and
dietary patterns over the 20-week period.
The resistance will be set progressively from 12 to 4 repetitions maximum (RM)
using repeated lifts before having a rest period. In study 1, the exercise group will
perform 2-4 sets of 4-12RM. In study 2, the low dosage training group will perform
only 1-2 sets of 4-12RM while the traditional training dosage group will perform 3-5
sets of 4-12RM for each exercise.
To ensure the progressive nature of the training program, both training groups will be
encouraged to work past a specific number of repetition-mark. When subjects are
able to perform more than the number of repetitions required, during a set the
workload will be increased by a 5 - 10% increment for the next set or training
session.
All training will take place on Monday and Thursday or Tuesday and Friday.
Test Measures
Prior to the commencement of training, after 10 and 20 weeks a series of tests will be
administered. The delay exercise group will only undertake the testing measures
before and after the first 20 weeks of intervention and then at 10 and 20 weeks of
their exercise intervention.
Body composition and bone density
•

Body composition (fat mass and lean mass) and bone density of the hip and

spine sites will be measured by dual x-ray absorptiometry (DXA), a routine
technique for the measurement of bone density. You will lie on a specially designed
table for approximately 10 minutes and a scanning arm will move above your total
body and above your hip and spine (separate scans for your whole body, hip and
spine). A low-dosage x-ray will pass from underneath the table to the scanning arm.
The total radiation dose for all scans undertaken during the study is very low only a
little more than normal background radiation and much less than, for example, an
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international flight. Note: height and hip/spine density will not be measured at 6
weeks, only before at week 10 and following the 20-week intervention period.
Muscle thickness
•

Muscle thickness of the elbow and knee flexors and extensors will be measured
by ultrasound images; this is a safe and non-invasive method to assess soft
tissues. The scanning probe will be coated with a water-soluble transmission gel
to provide acoustic contact to the surface and some ultrasound images will be
recorded from the muscles to determine thickness of the muscles. It will take
about 5 minutes to obtain all images, the images will be taken when you sit on a
chair or stand. All the testing will take place in the Exercise Physiology Research
Laboratory in building 19 on the Joondalup Campus.

PSA, Hormones, Immune system, Bone markers and Beta amyloid (Aβ)
•

PSA, Hormones, Immune system markers, Bone markers and Aβ will be
determine from blood samples to assess any changes in these physiological
markers. All the testing will take place in the Exercise Physiology Research
Laboratory in building 19 on the Joondalup Campus.

Muscle performance
•

Maximal muscle strength will be determined for each of the several upper and
lower body muscle exercises to be undertaken in the training program using
weight-training machines. The maximal strength is the most weight that can be
lifted one time using correct technique. This test will also be performed at week 6
and 18 for the immediate exercise group.

•

To determine muscle endurance of the upper and lower body, the number of
times you can lift a weight that is 70% of your 1RM will be determined.

Functional performance (only undertaken before at week 10 and after the 20-week
period)
•

Stair climb
You will be asked to ascend a flight of stairs (11 stairs) as fast as possible.

•

6-meter backwards walk
As a test of balance, participants will place one foot will behind the other and will
be asked to walk backwards 6 meters.

•

Chair rise
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You will be seated in a chair and asked to rise and sit 5 consecutive times,
without the use of your arms for support, as fast as possible.
•

400-meter corridor walk
You will be asked to walk 20 meters in a corridor, turn and return to the starting
position and repeat another 9 times.

•

Balance test
You will be asked to stand on a special platform under conditions of eyes open
and eyes closed. The platform will tilt slightly back and forth and the
surrounding walls will also move. You will be wearing a harness which will
support your body weight if you lose balance.

Before

muscle

performance

and

physical

function

tests

are

performed,

demonstrations, practice time, sufficient warm-up and stretching will be undertaken.
Lifestyle questionnaires (only undertaken before and after the 20-week period)
•

Quality of life will be assessed using a standardized questionnaire (Functional
Assessment of Cancer Therapy-Prostate, FACT-P) as well as Levels of Fatigue
(Functional Assessment of Cancer Therapy-anemia, FACT-an) that you can
complete at home.

•

Health history and Demographic information will be also assessed using
standardized questionnaires that you can complete at home

Risks
Resistance training may result in mild discomfort and muscle soreness, however, this
will be minimised by all sessions being supervised and commencing with a warm-up
and concluding with a cool-down period of mild stretching activities. It is also
possible that some muscle soreness may result from baseline performance testing,
however, all participants will undertake a warm-up period of stretching before
beginning the full exercise program. The risk of discomfort and muscle soreness will
also be minimised by a gradual increase in exercise intensity. Lastly, risk of falling
may exist in the performance of some tasks, however, participants will be closely
supervised and spotted to prevent a fall from occurring. In the event that an
emergency occurs, medical assistance will be obtained from the University Health
Service according to our established emergency procedures. Lastly, the discomforts
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associated with the blood drawing procedures are minimal. There is a risk that
sometimes bruising and infection may occur and that the arm might become sore.
Risk of bruising or infection from the blood draws will be minimized because all
blood draws will be performed by a trained phlebotomist (lab technician) with
extensive experience in both research and clinical settings. The total amount of blood
drawn during each testing session will not exceed 10 ml. No syringes, lancets,
needles or other devices capable of transmitting infection from one person to another
shall be reused. All of these items, which are disposable, will be destroyed after each
use. As an additional safeguard in preventing contamination new disposable gloves
will be required for all blood draws. All contaminated items will be disposed of
promptly in sharps containers
All information will be strictly confidential and kept safely locked in a filling cabinet
in the primary investigators office. Should publications result from this study, no
reference will be made to any individuals.
On completion of the intervention and measurements, a summary of study and
individual results will be made available to all participants.

PARTICIPATION IS VOLUNTARY AND SUBJECTS ARE FREE TO
WITHDRAW FROM THIS STUDY AT ANY TIME.
The study has been approved by Human Research Ethics Committee at Edith Cowan
University subjects will be free to withdraw from the study at any time. Contact
number, should there be any concerns relating to the project, is (08) 6304 2170 or
Email: research.ethics@ecu.edu.au.
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APPENDIX V - EXAMPLE OF UPPER AND LOWER BODY
EXERCISES USING THE HYDRAULIC RESISTANCE
EXERCISE EQUIPMENT

(Prostate Cancer Study)
Shoulder press/Lat pull down exercise

Leg extension/ leg curl exercise
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Biceps curl/ triceps extension

Chest press/ seated row
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APPENDIX VI - LETTER TO THE PARTICIPANT
Thank you for your interest in the study “Resistance Exercise in Men Receiving
Androgen Deprivation Therapy for Prostate Cancer.”
Please find attached:
1. A “Participant Information Sheet” outlining all aspects of the study;
2. A “Summary of Participants Information Sheet”;
3. A “Statement of Informed Consent” which you will be required to sign before
participating in the study;
4. A “Medical Doctor Consent Form” for your doctor;
5. A sheet titled “Hydraulic Resistance Training Exercises” which contains
photographic depictions of several exercises to be undertaken in the study;
and
6. A map of the Joondalup Campus.
As previously mentioned, all volunteers are required to obtain their doctor’s approval
prior to participation – please take the Medical Doctor form and the resistance
training exercises sheet to your doctor (GP) and have them complete and sign the
consent form (you may also want to show them the Participant Information sheet).
Following approval from your doctor, please contact me to arrange a meeting where
an orientation to the study will be provided and baseline measurements will
commence. At this meeting, please bring with you the “Medical Doctor Consent
Form” and “Statement of Informed Consent.”
If you have any questions, please don’t hesitate to contact me.
I look forward to hearing from you.
Best regards,
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Daniel Galvão MSc (PhD Candidate)
Ph:

Email: d.galvao@ecu.edu.au
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APPENDIX VII - HEALTH HISTORY QUESTIONNAIRE

Resistance training in men receiving androgen deprivation therapy for
prostate cancer

Medical History and Medications Questionnaire

___________________________________________________________________
Last Name

First Name

Middle

Initial

____________________________________________________________________
Date of Birth (Age)

Sex

Home Phone

___________________________________________________________________
Address

City, state

Post code

___________________________________________________________________
Family Physician

Emergency Contact (Name)

Phone
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MEDICAL HISTORY
GENERAL
1) Smoking
(a) Are you or have you ever been a smoker? Yes / No.
(b) Past / Current smoker?
(c) Age you started smoking:
(d) Age you quit smoking (for past smokers only):
(e) Average number of cigarettes smoked per day:

2) Drinking (alcohol)
(a) How many drinks do you usually have per week?

3) Body weight
(a) Has your weight fluctuated more than a few kilos in the last 12 months? Yes /
No.
(b) If ‘Yes’, approximately how many kilograms?

4) Physical activity
(a) What is your current level of physical activity? Active/ Inactive. Details:
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
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5) Medical condition
(a) When have you been diagnostic with prostate cancer?
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
(b) Which types of treatments have you undertaken (or are currently undertaking),
example: Androgen deprivation therapy, radiation therapy, systematic therapy
and/ or surgical castration? Please, specify the duration of treatment?
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________

(c) Do you know your PSA levels? When it was the last time that your PSA levels
were assessed?
____________________________________________________________________
____________________________________________________________________

(d) Do you have any other medical conditions? (chronic or serious illness) Yes /No.
Details:
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
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____________________________________________________________________

(b) Have you ever had any medical surgery? Yes /No. Details:
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________

6) Bones
(a) Have you been tested for osteoporosis before (DXA scan)? Yes / No
(b) What were the results? Normal bone density / Osteopenia / Osteoporosis
(c) Have you been placed on any medications to help strengthen your bones?
(i.e Fosamax, Actonel, Calcitriol) Yes / No (Include details of medications in
Medications Questionnaire.) :_________________
(d) Has your doctor recommended you do anything else to improve your bone
density? (i.e. weight bearing exercise, calcium supplements) Yes /No. Details:
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________

(e) Have you ever broken a bone as a result of minor trauma? (including vertebral
crush fractures) Yes / No. Details:
____________________________________________________________________
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____________________________________________________________________
AT THE PRESENT

(a) Do you experience shortness of breath while walking with others of your age?
Yes / No
Do you experience sudden tingling, numbness, or loss of feeling in arms, hands, legs,
feet, or face?
Yes / No

(b) Do you experience swelling of your feet and ankles?
Yes / No

(d) Do you get pains or cramps in your legs?
Yes / No

(e) Do you experience any discomfort in your chest?
Yes / No

(f) Have you ever been told that your blood pressure was abnormal? (If yes, do you
currently take any medication?)
Yes / No

(g) Have you ever been told that your serum cholesterol or triglyceride level was
high?
Yes / No
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(h) Do you have diabetes? (If yes, how is controlled?)
Yes / No. Details:
____________________________________________________________________
____________________________________________________________________
____________________________________________________________________

MEDICATIONS

Please list below medications you are currently taking. Fill out every column for
each medication you list.
MEDICATION

DURATION
(in months
and years)

Reason for taking (which medical condition)
and other comments
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APPENDIX VIII - DEMOGRAPHIC QUESTIONNAIRE
Resistance training in men receiving androgen deprivation therapy for
prostate cancer

Demographic Questionnaire
To assist us with our research, we would like to know a little about your background.
Please circle your response to each of the questions below.

1. How old are you?

20-30yrs

__________ years, or circle the correct age group

31-40yrs

41-50yrs

51-60yrs

61-70yrs

71-80yrs

>80

2. What is your current marital status?

Single Married

Defacto

Separated

Divorced

Widowed

3. What is the highest level of education you completed?

Primary

Secondary

Bachelor degree Higher degree

Trade

Other___________

4. What is your current occupation?
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Certificate/Diploma
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Homemaker

Labourer

Clerical

Trade

Computing

Retired

Professional

Management

Other ______________

5. What other responsibilities do you have? (Please circle as many as
appropriate)

Dependent children

Study

Elderly relatives

Care of sick/disabled relatives

Community volunteering No responsibilities

Other __________

6. In which country were you born?

Australia UK Asia Europe America

South America Africa

Other__________
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APPENDIX IX – ETHICS APPLICATION

is not included in this version of the thesis
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APPENDIX X - HYDRAULIC RESISTANCE TRAINING LOG
Name: ____________________________________________
Date
(sessions #)
SETS

(1)

1

2

(2)

3

4

1

2

Chest press
Seated Row
Leg press
Shoulder p.
Lat pull
Squat
Upper row
dips
Leg extens.
Leg curl
Biceps curl
Triceps ext.
Abs
Back ext.

153

(3)

3

4

1

2

3

4

APPENDIX XI - ISOTONIC RESISTANCE TRAINING LOG
Name: ____________________________________________
Date
(sessions #)
SETS

(1)

1

2

(2)

3

4

1

2

Chest press
Leg press
Lat pull
Squat
Leg
extension
Shoulder
press
Leg curl
Triceps ext.
Biceps curl
Abdominal
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(3)

3

4

1

2

3

4

